| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | channel activity | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPTE SLC9C1 CATSPER2 CATSPER4 CFTR SCN3A SCN5A SCNN1G PKD1L2 HVCN1 AQP4 RYR1 RYR2 KCNH3 ITPR3 | 9.82e-17 | 525 | 72 | 21 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPTE SLC9C1 CATSPER2 CATSPER4 CFTR SCN3A SCN5A SCNN1G PKD1L2 HVCN1 AQP4 RYR1 RYR2 KCNH3 ITPR3 | 1.02e-16 | 526 | 72 | 21 | GO:0022803 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPTE SLC9C1 CATSPER2 CATSPER4 CFTR SCN3A SCN5A SCNN1G PKD1L2 HVCN1 RYR1 RYR2 KCNH3 ITPR3 | 1.17e-16 | 459 | 72 | 20 | GO:0005216 |
| GeneOntologyMolecularFunction | transporter activity | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPTE SLC9A9 ATG9B SLC9C1 CATSPER2 ABCA6 SLC38A9 CATSPER4 CFTR SCN3A ATP6V0A4 SCN5A SCNN1G ATP13A3 RFT1 PKD1L2 HVCN1 AQP4 RYR1 RYR2 KCNH3 ITPR3 | 1.71e-15 | 1289 | 72 | 28 | GO:0005215 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPTE SLC9A9 SLC9C1 CATSPER2 CATSPER4 CFTR SCN3A ATP6V0A4 SCN5A SCNN1G ATP13A3 PKD1L2 HVCN1 RYR1 RYR2 KCNH3 ITPR3 | 2.69e-15 | 793 | 72 | 23 | GO:0015075 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F CATSPER2 CATSPER4 SCN3A SCN5A SCNN1G PKD1L2 HVCN1 RYR1 RYR2 KCNH3 ITPR3 | 3.83e-15 | 343 | 72 | 17 | GO:0005261 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F SLC9A9 SLC9C1 CATSPER2 CATSPER4 SCN3A ATP6V0A4 SCN5A SCNN1G ATP13A3 PKD1L2 HVCN1 RYR1 RYR2 KCNH3 ITPR3 | 1.05e-14 | 664 | 72 | 21 | GO:0008324 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F SLC9A9 SLC9C1 CATSPER2 CATSPER4 CFTR SCN3A ATP6V0A4 SCN5A SCNN1G PKD1L2 HVCN1 AQP4 RYR1 RYR2 KCNH3 ITPR3 | 1.23e-14 | 758 | 72 | 22 | GO:0015318 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPTE SLC9A9 SLC9C1 CATSPER2 ABCA6 SLC38A9 CATSPER4 CFTR SCN3A ATP6V0A4 SCN5A SCNN1G ATP13A3 PKD1L2 HVCN1 AQP4 RYR1 RYR2 KCNH3 ITPR3 | 1.75e-14 | 1180 | 72 | 26 | GO:0022857 |
| GeneOntologyMolecularFunction | calcium channel activity | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F CATSPER2 CATSPER4 PKD1L2 RYR1 RYR2 ITPR3 | 3.47e-14 | 129 | 72 | 12 | GO:0005262 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F SLC9A9 SLC9C1 CATSPER2 CATSPER4 SCN3A SCN5A SCNN1G PKD1L2 RYR1 RYR2 KCNH3 ITPR3 | 3.81e-14 | 465 | 72 | 18 | GO:0046873 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F SLC9A9 SLC9C1 CATSPER2 CATSPER4 SCN3A ATP6V0A4 SCN5A SCNN1G PKD1L2 HVCN1 RYR1 RYR2 KCNH3 ITPR3 | 4.37e-14 | 627 | 72 | 20 | GO:0022890 |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F CATSPER2 CATSPER4 RYR1 | 6.08e-14 | 46 | 72 | 9 | GO:0005245 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F CATSPER2 CATSPER4 PKD1L2 RYR1 RYR2 ITPR3 | 2.34e-13 | 151 | 72 | 12 | GO:0015085 |
| GeneOntologyMolecularFunction | gated channel activity | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F CATSPER2 CATSPER4 CFTR SCNN1G HVCN1 RYR1 RYR2 KCNH3 ITPR3 | 8.02e-13 | 334 | 72 | 15 | GO:0022836 |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 5.21e-12 | 14 | 72 | 6 | GO:0008331 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F CATSPER2 CATSPER4 HVCN1 RYR1 KCNH3 | 7.00e-12 | 152 | 72 | 11 | GO:0022843 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F CATSPER2 CATSPER4 HVCN1 RYR1 KCNH3 | 4.97e-11 | 182 | 72 | 11 | GO:0005244 |
| GeneOntologyMolecularFunction | voltage-gated channel activity | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F CATSPER2 CATSPER4 HVCN1 RYR1 KCNH3 | 5.59e-11 | 184 | 72 | 11 | GO:0022832 |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 1.93e-08 | 9 | 72 | 4 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 1.93e-08 | 9 | 72 | 4 | GO:0099626 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | TAS2R1 OR4C3 OR6B3 CALCR OR6N2 OR6C1 ADGRE4P GPR141 GCGR PTAFR OR5AR1 OR6B2 CRHR1 CRHR2 OR52J3 | 4.75e-07 | 884 | 72 | 15 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | EPHB6 TAS2R1 OR4C3 OR6B3 CALCR OR6N2 OR6C1 ADGRE4P GPR141 GCGR ACVR1B PTAFR OR5AR1 OR6B2 CRHR1 CRHR2 OR52J3 | 4.63e-06 | 1353 | 72 | 17 | GO:0004888 |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 5.87e-06 | 33 | 72 | 4 | GO:0005217 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 6.12e-06 | 193 | 72 | 7 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 7.01e-06 | 197 | 72 | 7 | GO:0022834 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.14e-05 | 140 | 72 | 6 | GO:0099094 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 3.53e-05 | 18 | 72 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | corticotropin-releasing hormone receptor activity | 3.84e-05 | 3 | 72 | 2 | GO:0043404 | |
| GeneOntologyMolecularFunction | corticotrophin-releasing factor receptor activity | 3.84e-05 | 3 | 72 | 2 | GO:0015056 | |
| GeneOntologyMolecularFunction | peptide hormone binding | 4.61e-05 | 55 | 72 | 4 | GO:0017046 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 7.66e-05 | 4 | 72 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | amide binding | 1.01e-04 | 299 | 72 | 7 | GO:0033218 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 1.27e-04 | 5 | 72 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.81e-04 | 230 | 72 | 6 | GO:0005516 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.88e-04 | 31 | 72 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 1.91e-04 | 6 | 72 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | chloride channel inhibitor activity | 2.66e-04 | 7 | 72 | 2 | GO:0019869 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 3.82e-04 | 171 | 72 | 5 | GO:0015081 | |
| GeneOntologyMolecularFunction | hormone binding | 5.25e-04 | 103 | 72 | 4 | GO:0042562 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 6.50e-04 | 109 | 72 | 4 | GO:0042626 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 7.35e-04 | 49 | 72 | 3 | GO:0140359 | |
| GeneOntologyMolecularFunction | sodium channel activity | 8.75e-04 | 52 | 72 | 3 | GO:0005272 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | 9.15e-04 | 431 | 72 | 7 | GO:0004984 | |
| GeneOntologyMolecularFunction | potassium:proton antiporter activity | 1.13e-03 | 14 | 72 | 2 | GO:0015386 | |
| GeneOntologyMolecularFunction | odorant binding | 1.15e-03 | 127 | 72 | 4 | GO:0005549 | |
| GeneOntologyMolecularFunction | chloride channel regulator activity | 1.31e-03 | 15 | 72 | 2 | GO:0017081 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 1.36e-03 | 133 | 72 | 4 | GO:0008528 | |
| GeneOntologyMolecularFunction | sodium:proton antiporter activity | 1.49e-03 | 16 | 72 | 2 | GO:0015385 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 1.65e-03 | 140 | 72 | 4 | GO:0001653 | |
| GeneOntologyMolecularFunction | solute:potassium antiporter activity | 2.11e-03 | 19 | 72 | 2 | GO:0022821 | |
| GeneOntologyMolecularFunction | ankyrin binding | 3.09e-03 | 23 | 72 | 2 | GO:0030506 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 3.92e-03 | 178 | 72 | 4 | GO:0015399 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 3.94e-03 | 26 | 72 | 2 | GO:0005248 | |
| GeneOntologyMolecularFunction | metal cation:proton antiporter activity | 4.25e-03 | 27 | 72 | 2 | GO:0051139 | |
| GeneOntologyMolecularFunction | calcium-activated cation channel activity | 4.25e-03 | 27 | 72 | 2 | GO:0005227 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 4.62e-03 | 93 | 72 | 3 | GO:0097110 | |
| GeneOntologyMolecularFunction | proton transmembrane transporter activity | 4.76e-03 | 188 | 72 | 4 | GO:0015078 | |
| GeneOntologyMolecularFunction | calcium ion binding | 5.44e-03 | 749 | 72 | 8 | GO:0005509 | |
| GeneOntologyMolecularFunction | alpha-actinin binding | 5.57e-03 | 31 | 72 | 2 | GO:0051393 | |
| GeneOntologyMolecularFunction | monoatomic ion-gated channel activity | 5.57e-03 | 31 | 72 | 2 | GO:0022839 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 5.98e-03 | 102 | 72 | 3 | GO:0001540 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 7.45e-03 | 477 | 72 | 6 | GO:0022804 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 7.46e-03 | 36 | 72 | 2 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 7.46e-03 | 36 | 72 | 2 | GO:0015662 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 9.72e-03 | 231 | 72 | 4 | GO:0005085 | |
| GeneOntologyMolecularFunction | protein phosphatase 2A binding | 1.01e-02 | 42 | 72 | 2 | GO:0051721 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 1.05e-02 | 43 | 72 | 2 | GO:0140828 | |
| GeneOntologyMolecularFunction | actinin binding | 1.05e-02 | 43 | 72 | 2 | GO:0042805 | |
| GeneOntologyMolecularFunction | G-protein alpha-subunit binding | 1.05e-02 | 43 | 72 | 2 | GO:0001965 | |
| GeneOntologyMolecularFunction | ion channel inhibitor activity | 1.30e-02 | 48 | 72 | 2 | GO:0008200 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F SLC9A9 SLC9C1 CATSPER2 CATSPER4 CFTR SCN3A ATP6V0A4 SCN5A SCNN1G ATP13A3 PKD1L2 HVCN1 CRHR1 RYR1 RYR2 KCNH3 ITPR3 | 5.26e-14 | 942 | 72 | 23 | GO:0098655 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPTE SLC9A9 SLC9C1 CATSPER2 CATSPER4 CFTR SCN3A ATP6V0A4 SCN5A SCNN1G ATP13A3 PKD1L2 HVCN1 CRHR1 RYR1 RYR2 KCNH3 ITPR3 | 2.00e-13 | 1115 | 72 | 24 | GO:0034220 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F SLC9A9 SLC9C1 CATSPER2 CATSPER4 CFTR SCN3A ATP6V0A4 SCN5A SCNN1G PKD1L2 HVCN1 CRHR1 RYR1 RYR2 KCNH3 ITPR3 | 3.38e-13 | 922 | 72 | 22 | GO:0098662 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F SLC9A9 SLC9C1 CATSPER2 CATSPER4 CFTR SCN3A ATP6V0A4 SCN5A SCNN1G ATP13A3 PKD1L2 HVCN1 CRHR1 CRHR2 RYR1 RYR2 KCNH3 ITPR3 | 4.43e-13 | 1157 | 72 | 24 | GO:0006812 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPTE SLC9A9 SLC9C1 CATSPER2 CATSPER4 CFTR SCN3A ATP6V0A4 SCN5A SCNN1G ATP13A3 PKD1L2 HVCN1 CRHR1 CRHR2 RYR1 RYR2 KCNH3 ITPR3 | 2.28e-12 | 1374 | 72 | 25 | GO:0006811 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F SLC9A9 SLC9C1 CATSPER2 CATSPER4 CFTR SCN3A ATP6V0A4 SCN5A SCNN1G PKD1L2 HVCN1 CRHR1 RYR1 RYR2 KCNH3 ITPR3 | 2.38e-12 | 1017 | 72 | 22 | GO:0098660 |
| GeneOntologyBiologicalProcess | metal ion transport | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F SLC9A9 SLC9C1 CATSPER2 CATSPER4 CFTR SCN3A SCN5A SCNN1G PKD1L2 CRHR1 CRHR2 RYR1 RYR2 KCNH3 ITPR3 | 1.48e-11 | 1000 | 72 | 21 | GO:0030001 |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F SLC9A9 SLC9C1 SCN5A SCNN1G | 6.47e-11 | 142 | 72 | 10 | GO:0099587 |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F SLC9A9 SLC9C1 SCN5A SCNN1G | 6.47e-11 | 142 | 72 | 10 | GO:0098659 |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F SLC9A9 SLC9C1 CFTR ATP6V0A4 CD40 SCNN1G ATP13A3 GRINA HVCN1 AQP4 CRHR2 RYR1 RYR2 ITPR3 | 8.16e-11 | 866 | 72 | 19 | GO:0055082 |
| GeneOntologyBiologicalProcess | cellular homeostasis | CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F SLC9A9 SLC9C1 CFTR ATP6V0A4 CD40 SCNN1G ATP13A3 GRINA HVCN1 AQP4 CRHR2 RYR1 RYR2 ITPR3 | 6.67e-10 | 981 | 72 | 19 | GO:0019725 |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F CATSPER2 CATSPER4 PKD1L2 CRHR1 RYR1 RYR2 ITPR3 | 8.91e-10 | 392 | 72 | 13 | GO:0070588 |
| GeneOntologyBiologicalProcess | calcium ion transport | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F CATSPER2 CATSPER4 PKD1L2 CRHR1 CRHR2 RYR1 RYR2 ITPR3 | 2.10e-09 | 509 | 72 | 14 | GO:0006816 |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | CACNA1A CACNA1C CACNA1F SLC9A9 SLC9C1 CFTR ATP6V0A4 CD40 SCNN1G ATP13A3 GRINA HVCN1 RYR1 RYR2 ITPR3 | 2.43e-09 | 611 | 72 | 15 | GO:0030003 |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | CACNA1A CACNA1C CACNA1F SLC9A9 SLC9C1 CFTR ATP6V0A4 CD40 SCNN1G ATP13A3 GRINA HVCN1 RYR1 RYR2 ITPR3 | 3.09e-09 | 622 | 72 | 15 | GO:0006873 |
| GeneOntologyBiologicalProcess | chemical homeostasis | CACNA1A CACNA1C CACNA1D CACNA1E CACNA1F SLC9A9 SLC9C1 CFTR ATP6V0A4 CD40 SCNN1G GCGR ATP13A3 GRINA HVCN1 AQP4 CRHR2 RYR1 RYR2 ITPR3 | 5.72e-09 | 1249 | 72 | 20 | GO:0048878 |
| GeneOntologyBiologicalProcess | import across plasma membrane | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F SLC9A9 SLC9C1 SCN5A SCNN1G | 7.16e-09 | 230 | 72 | 10 | GO:0098739 |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 1.60e-08 | 48 | 72 | 6 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 1.60e-08 | 48 | 72 | 6 | GO:1902656 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | CACNA1A CACNA1C CACNA1F SLC9A9 SLC9C1 CFTR ATP6V0A4 CD40 SCNN1G ATP13A3 GRINA HVCN1 RYR1 RYR2 ITPR3 | 1.66e-08 | 705 | 72 | 15 | GO:0055080 |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | CACNA1A CACNA1C CACNA1F SLC9A9 SLC9C1 CFTR ATP6V0A4 CD40 SCNN1G ATP13A3 GRINA HVCN1 RYR1 RYR2 ITPR3 | 2.07e-08 | 717 | 72 | 15 | GO:0050801 |
| GeneOntologyBiologicalProcess | calcium ion import | 5.04e-08 | 98 | 72 | 7 | GO:0070509 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F RYR1 RYR2 ITPR3 | 6.41e-08 | 217 | 72 | 9 | GO:0097553 |
| GeneOntologyBiologicalProcess | sensory perception | CACNA1D CACNA1E CACNA1F TAS2R1 OR4C3 OR6B3 OR6N2 OR6C1 ATP6V0A4 SCNN1G OR5AR1 OR6B2 AQP4 RTP4 ITPR3 OR52J3 | 6.66e-07 | 1072 | 72 | 16 | GO:0007600 |
| GeneOntologyBiologicalProcess | response to pain | 9.33e-07 | 51 | 72 | 5 | GO:0048265 | |
| GeneOntologyBiologicalProcess | parturition | 9.52e-07 | 22 | 72 | 4 | GO:0007567 | |
| GeneOntologyBiologicalProcess | detection of stimulus | CACNA1F TAS2R1 OR4C3 OR6B3 OR6N2 OR6C1 CRTAM PKD1L2 OR5AR1 OR6B2 RTP4 RYR2 OR52J3 | 1.12e-06 | 722 | 72 | 13 | GO:0051606 |
| GeneOntologyBiologicalProcess | sodium ion import across plasma membrane | 2.25e-06 | 27 | 72 | 4 | GO:0098719 | |
| GeneOntologyBiologicalProcess | maternal process involved in parturition | 2.26e-06 | 8 | 72 | 3 | GO:0060137 | |
| GeneOntologyBiologicalProcess | blood circulation | CACNA1B CACNA1C CACNA1D CACNA1E CFTR SCN3A SCN5A SCNN1G GCGR PTAFR CRHR2 RYR2 | 2.29e-06 | 648 | 72 | 12 | GO:0008015 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 2.50e-06 | 62 | 72 | 5 | GO:0086002 | |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | TAS2R1 OR4C3 OR6B3 OR6N2 OR6C1 SCNN1G OR5AR1 OR6B2 RTP4 ITPR3 OR52J3 | 2.89e-06 | 547 | 72 | 11 | GO:0007606 |
| GeneOntologyBiologicalProcess | membrane depolarization | 4.10e-06 | 121 | 72 | 6 | GO:0051899 | |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | 4.30e-06 | 359 | 72 | 9 | GO:0006874 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | CACNA1D TAS2R1 OR4C3 OR6B3 CALCR OR6N2 OR6C1 ADGRE4P GPR141 GCGR PTAFR OR5AR1 OR6B2 CRHR1 CRHR2 ITPR3 OR52J3 | 4.52e-06 | 1395 | 72 | 17 | GO:0007186 |
| GeneOntologyBiologicalProcess | behavioral response to pain | 4.56e-06 | 32 | 72 | 4 | GO:0048266 | |
| GeneOntologyBiologicalProcess | SA node cell to atrial cardiac muscle cell signaling | 4.81e-06 | 10 | 72 | 3 | GO:0086018 | |
| GeneOntologyBiologicalProcess | SA node cell action potential | 4.81e-06 | 10 | 72 | 3 | GO:0086015 | |
| GeneOntologyBiologicalProcess | cell-cell signaling involved in cardiac conduction | 5.85e-06 | 34 | 72 | 4 | GO:0086019 | |
| GeneOntologyBiologicalProcess | regulation of heart rate | 5.93e-06 | 129 | 72 | 6 | GO:0002027 | |
| GeneOntologyBiologicalProcess | SA node cell to atrial cardiac muscle cell communication | 6.60e-06 | 11 | 72 | 3 | GO:0086070 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 7.39e-06 | 36 | 72 | 4 | GO:0086010 | |
| GeneOntologyBiologicalProcess | circulatory system process | CACNA1B CACNA1C CACNA1D CACNA1E CFTR SCN3A SCN5A SCNN1G GCGR PTAFR CRHR2 RYR2 | 8.05e-06 | 733 | 72 | 12 | GO:0003013 |
| GeneOntologyBiologicalProcess | calcium ion homeostasis | 8.21e-06 | 389 | 72 | 9 | GO:0055074 | |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell signaling | 8.77e-06 | 12 | 72 | 3 | GO:0086027 | |
| GeneOntologyBiologicalProcess | AV node cell action potential | 8.77e-06 | 12 | 72 | 3 | GO:0086016 | |
| GeneOntologyBiologicalProcess | heart contraction | 9.28e-06 | 298 | 72 | 8 | GO:0060047 | |
| GeneOntologyBiologicalProcess | positive regulation of adenylate cyclase activity | 1.13e-05 | 40 | 72 | 4 | GO:0045762 | |
| GeneOntologyBiologicalProcess | heart process | 1.21e-05 | 309 | 72 | 8 | GO:0003015 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 1.33e-05 | 87 | 72 | 5 | GO:0086001 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | TAS2R1 OR4C3 OR6B3 OR6N2 OR6C1 OR5AR1 OR6B2 RTP4 RYR2 OR52J3 | 1.34e-05 | 524 | 72 | 10 | GO:0009593 |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell communication | 1.80e-05 | 15 | 72 | 3 | GO:0086067 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 1.84e-05 | 93 | 72 | 5 | GO:0086003 | |
| GeneOntologyBiologicalProcess | regulation of intracellular pH | 1.94e-05 | 94 | 72 | 5 | GO:0051453 | |
| GeneOntologyBiologicalProcess | exocytosis | 1.96e-05 | 434 | 72 | 9 | GO:0006887 | |
| GeneOntologyBiologicalProcess | glucose homeostasis | 2.30e-05 | 338 | 72 | 8 | GO:0042593 | |
| GeneOntologyBiologicalProcess | carbohydrate homeostasis | 2.35e-05 | 339 | 72 | 8 | GO:0033500 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | CACNA1A CYP1A1 CACNA1C CACNA1D CACNA1E KALRN DHCR7 CFTR VAMP8 CRHR1 CRHR2 | 2.36e-05 | 684 | 72 | 11 | GO:0010817 |
| GeneOntologyBiologicalProcess | positive regulation of cyclase activity | 2.36e-05 | 48 | 72 | 4 | GO:0031281 | |
| GeneOntologyBiologicalProcess | positive regulation of lyase activity | 2.57e-05 | 49 | 72 | 4 | GO:0051349 | |
| GeneOntologyBiologicalProcess | regulation of heart contraction | 2.59e-05 | 249 | 72 | 7 | GO:0008016 | |
| GeneOntologyBiologicalProcess | regulation of cellular pH | 2.75e-05 | 101 | 72 | 5 | GO:0030641 | |
| GeneOntologyBiologicalProcess | regulation of hormone secretion | 3.26e-05 | 355 | 72 | 8 | GO:0046883 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | CACNA1F TAS2R1 OR4C3 OR6B3 OR6N2 OR6C1 OR5AR1 OR6B2 RTP4 OR52J3 | 3.29e-05 | 582 | 72 | 10 | GO:0050906 |
| GeneOntologyBiologicalProcess | membrane depolarization during atrial cardiac muscle cell action potential | 3.60e-05 | 3 | 72 | 2 | GO:0098912 | |
| GeneOntologyBiologicalProcess | atrial cardiac muscle cell to AV node cell communication | 3.80e-05 | 19 | 72 | 3 | GO:0086066 | |
| GeneOntologyBiologicalProcess | atrial cardiac muscle cell to AV node cell signaling | 3.80e-05 | 19 | 72 | 3 | GO:0086026 | |
| GeneOntologyBiologicalProcess | atrial cardiac muscle cell action potential | 3.80e-05 | 19 | 72 | 3 | GO:0086014 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | 4.67e-05 | 485 | 72 | 9 | GO:0050907 | |
| GeneOntologyBiologicalProcess | regulation of secretion by cell | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E KALRN CFTR PTAFR VAMP8 CRHR1 CRHR2 | 4.84e-05 | 740 | 72 | 11 | GO:1903530 |
| GeneOntologyBiologicalProcess | sodium ion transport | 4.88e-05 | 275 | 72 | 7 | GO:0006814 | |
| GeneOntologyBiologicalProcess | regulation of adenylate cyclase activity | 5.37e-05 | 59 | 72 | 4 | GO:0045761 | |
| GeneOntologyBiologicalProcess | cell communication involved in cardiac conduction | 5.37e-05 | 59 | 72 | 4 | GO:0086065 | |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | CACNA1A CACNA1C CACNA1F CD40 SCNN1G ATP13A3 GRINA RYR1 RYR2 ITPR3 | 5.76e-05 | 622 | 72 | 10 | GO:0098771 |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | CACNA1B CYP1A1 CACNA1C CALCR CFTR SCN5A CD40 SCNN1G PTAFR CRHR1 RYR1 RYR2 ITPR3 | 6.06e-05 | 1048 | 72 | 13 | GO:0014070 |
| GeneOntologyBiologicalProcess | regulation of membrane depolarization | 6.13e-05 | 61 | 72 | 4 | GO:0003254 | |
| GeneOntologyBiologicalProcess | regulation of pH | 6.28e-05 | 120 | 72 | 5 | GO:0006885 | |
| GeneOntologyBiologicalProcess | membrane depolarization during cardiac muscle cell action potential | 6.87e-05 | 23 | 72 | 3 | GO:0086012 | |
| GeneOntologyBiologicalProcess | regulated exocytosis | 6.97e-05 | 291 | 72 | 7 | GO:0045055 | |
| GeneOntologyBiologicalProcess | multicellular organismal response to stress | 7.92e-05 | 126 | 72 | 5 | GO:0033555 | |
| GeneOntologyBiologicalProcess | positive regulation of secretion by cell | 8.10e-05 | 404 | 72 | 8 | GO:1903532 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 8.22e-05 | 127 | 72 | 5 | GO:0070252 | |
| GeneOntologyBiologicalProcess | signal release | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E KALRN CFTR VAMP8 CRHR1 CRHR2 | 8.63e-05 | 653 | 72 | 10 | GO:0023061 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 8.79e-05 | 208 | 72 | 6 | GO:0035725 | |
| GeneOntologyBiologicalProcess | regulation of secretion | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E KALRN CFTR PTAFR VAMP8 CRHR1 CRHR2 | 9.83e-05 | 801 | 72 | 11 | GO:0051046 |
| GeneOntologyBiologicalProcess | regulation of cyclase activity | 9.94e-05 | 69 | 72 | 4 | GO:0031279 | |
| GeneOntologyBiologicalProcess | sensory perception of taste | 1.05e-04 | 70 | 72 | 4 | GO:0050909 | |
| GeneOntologyBiologicalProcess | hormone secretion | 1.06e-04 | 420 | 72 | 8 | GO:0046879 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 1.11e-04 | 217 | 72 | 6 | GO:0006941 | |
| GeneOntologyBiologicalProcess | membrane depolarization during SA node cell action potential | 1.19e-04 | 5 | 72 | 2 | GO:0086046 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | 1.19e-04 | 5 | 72 | 2 | GO:1904879 | |
| GeneOntologyBiologicalProcess | regulation of lyase activity | 1.24e-04 | 73 | 72 | 4 | GO:0051339 | |
| GeneOntologyBiologicalProcess | hormone transport | 1.29e-04 | 432 | 72 | 8 | GO:0009914 | |
| GeneOntologyBiologicalProcess | positive regulation of cytosolic calcium ion concentration | 1.32e-04 | 224 | 72 | 6 | GO:0007204 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transport | 1.33e-04 | 323 | 72 | 7 | GO:0051924 | |
| GeneOntologyBiologicalProcess | positive regulation of secretion | 1.35e-04 | 435 | 72 | 8 | GO:0051047 | |
| GeneOntologyBiologicalProcess | regulation of blood circulation | 1.41e-04 | 326 | 72 | 7 | GO:1903522 | |
| GeneOntologyBiologicalProcess | organic cation transport | 1.54e-04 | 145 | 72 | 5 | GO:0015695 | |
| GeneOntologyBiologicalProcess | regulation of exocytosis | 1.63e-04 | 233 | 72 | 6 | GO:0017157 | |
| GeneOntologyBiologicalProcess | peptide hormone secretion | 1.64e-04 | 334 | 72 | 7 | GO:0030072 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F CATSPER2 CATSPER4 RYR1 | 4.04e-14 | 46 | 72 | 9 | GO:0005891 |
| GeneOntologyCellularComponent | calcium channel complex | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F CATSPER2 CATSPER4 RYR1 RYR2 | 6.41e-14 | 73 | 72 | 10 | GO:0034704 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F CATSPER2 CATSPER4 CFTR SCN3A SCN5A SCNN1G HVCN1 RYR1 RYR2 KCNH3 | 1.56e-13 | 378 | 72 | 16 | GO:0034702 |
| GeneOntologyCellularComponent | cation channel complex | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F CATSPER2 CATSPER4 SCN3A SCN5A SCNN1G RYR1 RYR2 | 1.30e-12 | 235 | 72 | 13 | GO:0034703 |
| GeneOntologyCellularComponent | transmembrane transporter complex | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F CATSPER2 CATSPER4 CFTR SCN3A ATP6V0A4 SCN5A SCNN1G HVCN1 RYR1 RYR2 KCNH3 | 1.73e-12 | 523 | 72 | 17 | GO:1902495 |
| GeneOntologyCellularComponent | transporter complex | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F CATSPER2 CATSPER4 CFTR SCN3A ATP6V0A4 SCN5A SCNN1G HVCN1 RYR1 RYR2 KCNH3 | 3.86e-12 | 550 | 72 | 17 | GO:1990351 |
| GeneOntologyCellularComponent | membrane protein complex | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F CALCR CATSPER2 SLC38A9 CATSPER4 CFTR SCN3A ATP6V0A4 SCN5A CD40 SCNN1G ACVR1B VAMP8 HVCN1 RYR1 RYR2 KCNH3 | 3.10e-09 | 1498 | 72 | 22 | GO:0098796 |
| GeneOntologyCellularComponent | plasma membrane protein complex | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F CALCR CATSPER2 CATSPER4 SCN3A SCN5A CD40 ACVR1B RYR1 | 3.91e-07 | 785 | 72 | 14 | GO:0098797 |
| GeneOntologyCellularComponent | neuronal cell body | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F CALCR KALRN CFTR SCN3A CD40 CRHR1 CRHR2 ITPR3 | 8.18e-07 | 835 | 72 | 14 | GO:0043025 |
| GeneOntologyCellularComponent | cell body | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F CALCR KALRN CFTR SCN3A CD40 CRHR1 CRHR2 ITPR3 | 2.87e-06 | 929 | 72 | 14 | GO:0044297 |
| GeneOntologyCellularComponent | somatodendritic compartment | EPHB6 CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F CALCR KALRN FAT3 CFTR SCN3A CD40 CRHR1 CRHR2 ITPR3 | 3.30e-06 | 1228 | 72 | 16 | GO:0036477 |
| GeneOntologyCellularComponent | sarcolemma | 4.10e-06 | 190 | 72 | 7 | GO:0042383 | |
| GeneOntologyCellularComponent | T-tubule | 7.78e-06 | 79 | 72 | 5 | GO:0030315 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 4.24e-05 | 112 | 72 | 5 | GO:0055038 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 9.07e-05 | 212 | 72 | 6 | GO:0030666 | |
| GeneOntologyCellularComponent | cell surface | EPHB6 CACNA1C CACNA1D CFTR SCN5A CD40 ADGRE4P SCNN1G ADAM30 ACVR1B VAMP8 AQP4 CD163 | 9.56e-05 | 1111 | 72 | 13 | GO:0009986 |
| GeneOntologyCellularComponent | perikaryon | 1.20e-04 | 223 | 72 | 6 | GO:0043204 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | SLC9A9 ATG9B SPACA1 SLC38A9 CFTR ATP6V0A4 ADAM30 ATP13A3 PTAFR VAMP8 HVCN1 AQP4 CD163 ITPR3 | 1.27e-04 | 1307 | 72 | 14 | GO:0030659 |
| GeneOntologyCellularComponent | sodium channel complex | 1.34e-04 | 29 | 72 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | vesicle membrane | SLC9A9 ATG9B SPACA1 SLC38A9 CFTR ATP6V0A4 ADAM30 ATP13A3 PTAFR VAMP8 HVCN1 AQP4 CD163 ITPR3 | 1.47e-04 | 1325 | 72 | 14 | GO:0012506 |
| GeneOntologyCellularComponent | Z disc | 1.74e-04 | 151 | 72 | 5 | GO:0030018 | |
| GeneOntologyCellularComponent | phagocytic vesicle membrane | 1.94e-04 | 83 | 72 | 4 | GO:0030670 | |
| GeneOntologyCellularComponent | presynapse | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E KALRN WDR7 IQSEC2 ATP6V0A4 CRHR2 ITPR3 | 2.11e-04 | 886 | 72 | 11 | GO:0098793 |
| GeneOntologyCellularComponent | endosome membrane | SLC9A9 ATG9B SLC38A9 CFTR ATP6V0A4 ADAM30 ATP13A3 VAMP8 AQP4 | 2.17e-04 | 602 | 72 | 9 | GO:0010008 |
| GeneOntologyCellularComponent | I band | 2.71e-04 | 166 | 72 | 5 | GO:0031674 | |
| GeneOntologyCellularComponent | late endosome membrane | 3.83e-04 | 179 | 72 | 5 | GO:0031902 | |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 5.17e-04 | 10 | 72 | 2 | GO:0014701 | |
| GeneOntologyCellularComponent | sarcoplasm | 6.49e-04 | 114 | 72 | 4 | GO:0016528 | |
| GeneOntologyCellularComponent | dendrite | EPHB6 CACNA1A CACNA1B CACNA1C CACNA1D FAT3 CFTR CRHR1 CRHR2 ITPR3 | 6.88e-04 | 858 | 72 | 10 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | EPHB6 CACNA1A CACNA1B CACNA1C CACNA1D FAT3 CFTR CRHR1 CRHR2 ITPR3 | 7.00e-04 | 860 | 72 | 10 | GO:0097447 |
| GeneOntologyCellularComponent | L-type voltage-gated calcium channel complex | 7.55e-04 | 12 | 72 | 2 | GO:1990454 | |
| GeneOntologyCellularComponent | recycling endosome | 1.01e-03 | 222 | 72 | 5 | GO:0055037 | |
| GeneOntologyCellularComponent | CatSper complex | 1.19e-03 | 15 | 72 | 2 | GO:0036128 | |
| GeneOntologyCellularComponent | varicosity | 1.19e-03 | 15 | 72 | 2 | GO:0043196 | |
| GeneOntologyCellularComponent | late endosome | 1.26e-03 | 348 | 72 | 6 | GO:0005770 | |
| GeneOntologyCellularComponent | presynaptic active zone | 1.43e-03 | 141 | 72 | 4 | GO:0048786 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 1.54e-03 | 17 | 72 | 2 | GO:0001518 | |
| GeneOntologyCellularComponent | sarcomere | 1.68e-03 | 249 | 72 | 5 | GO:0030017 | |
| GeneOntologyCellularComponent | endosome | SLC9A9 ATG9B SLC38A9 CFTR ATP6V0A4 ADAM30 GCGR ATP13A3 VAMP8 AQP4 CRHR1 | 2.06e-03 | 1167 | 72 | 11 | GO:0005768 |
| GeneOntologyCellularComponent | endocytic vesicle | 2.08e-03 | 384 | 72 | 6 | GO:0030139 | |
| GeneOntologyCellularComponent | phagocytic vesicle | 2.12e-03 | 157 | 72 | 4 | GO:0045335 | |
| GeneOntologyCellularComponent | myofibril | 2.51e-03 | 273 | 72 | 5 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 3.26e-03 | 290 | 72 | 5 | GO:0043292 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 3.49e-03 | 88 | 72 | 3 | GO:0016529 | |
| GeneOntologyCellularComponent | apical part of cell | 4.23e-03 | 592 | 72 | 7 | GO:0045177 | |
| GeneOntologyCellularComponent | ribbon synapse | 5.43e-03 | 32 | 72 | 2 | GO:0097470 | |
| GeneOntologyCellularComponent | secretory granule membrane | 5.54e-03 | 329 | 72 | 5 | GO:0030667 | |
| GeneOntologyCellularComponent | early endosome membrane | 6.18e-03 | 212 | 72 | 4 | GO:0031901 | |
| GeneOntologyCellularComponent | apical plasma membrane | 6.62e-03 | 487 | 72 | 6 | GO:0016324 | |
| GeneOntologyCellularComponent | vacuolar membrane | 8.00e-03 | 507 | 72 | 6 | GO:0005774 | |
| GeneOntologyCellularComponent | nuclear outer membrane | 8.39e-03 | 40 | 72 | 2 | GO:0005640 | |
| GeneOntologyCellularComponent | side of membrane | 1.03e-02 | 875 | 72 | 8 | GO:0098552 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 1.05e-02 | 45 | 72 | 2 | GO:0033017 | |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum | 1.10e-02 | 46 | 72 | 2 | GO:0005790 | |
| GeneOntologyCellularComponent | cilium | 1.19e-02 | 898 | 72 | 8 | GO:0005929 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | 1.28e-02 | 1293 | 72 | 10 | GO:0005789 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 1.29e-02 | 405 | 72 | 5 | GO:0045211 | |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | 1.32e-02 | 1299 | 72 | 10 | GO:0098827 | |
| MousePheno | abnormal miniature excitatory postsynaptic currents | 6.64e-06 | 116 | 56 | 6 | MP:0004753 | |
| MousePheno | atrial fibrillation | 7.16e-06 | 10 | 56 | 3 | MP:0008543 | |
| MousePheno | abnormal respiratory epithelial sodium ion transmembrane transport | 1.58e-05 | 2 | 56 | 2 | MP:0014181 | |
| MousePheno | decreased respiratory epithelial sodium ion transmembrane transport | 1.58e-05 | 2 | 56 | 2 | MP:0014182 | |
| MousePheno | fibrillation | 2.15e-05 | 14 | 56 | 3 | MP:0006109 | |
| MousePheno | abnormal myocardial fiber physiology | 2.92e-05 | 90 | 56 | 5 | MP:0004215 | |
| MousePheno | abnormal behavioral response to xenobiotic | 2.94e-05 | 309 | 56 | 8 | MP:0009745 | |
| MousePheno | abnormal social/conspecific interaction behavior | CACNA1A CACNA1B CACNA1C SLC9A9 KALRN IQSEC2 CRHR2 CHST3 ITPR3 | 4.04e-05 | 421 | 56 | 9 | MP:0002557 |
| MousePheno | abnormal nervous system electrophysiology | 4.59e-05 | 329 | 56 | 8 | MP:0002272 | |
| MousePheno | abnormal myocardial fiber sodium currents | 4.72e-05 | 3 | 56 | 2 | MP:0020347 | |
| MousePheno | abnormal intestinal epithelial sodium ion transmembrane transport | 4.72e-05 | 3 | 56 | 2 | MP:0014204 | |
| MousePheno | decreased intestinal epithelial sodium ion transmembrane transport | 4.72e-05 | 3 | 56 | 2 | MP:0014206 | |
| MousePheno | abnormal intestinal epithelial transmembrane transport | 4.72e-05 | 3 | 56 | 2 | MP:0014202 | |
| MousePheno | abnormal respiratory epithelial transmembrane transport | 9.41e-05 | 4 | 56 | 2 | MP:0014026 | |
| MousePheno | abnormal sarcoplasmic reticulum morphology | 1.02e-04 | 23 | 56 | 3 | MP:0004088 | |
| MousePheno | irregular heartbeat | 1.84e-04 | 71 | 56 | 4 | MP:0001636 | |
| MousePheno | abnormal action potential | 1.87e-04 | 133 | 56 | 5 | MP:0005402 | |
| MousePheno | abnormal synaptic transmission | CACNA1A CACNA1B CACNA1C CACNA1E SLC9A9 KALRN DHCR7 IQSEC2 TSPAN6 TMEM138 RYR2 KCNH3 CHST3 | 2.44e-04 | 1070 | 56 | 13 | MP:0003635 |
| MousePheno | abnormal liquid preference | 2.53e-04 | 31 | 56 | 3 | MP:0001423 | |
| MousePheno | abnormal synaptic physiology | CACNA1A CACNA1B CACNA1C CACNA1E SLC9A9 KALRN DHCR7 IQSEC2 TSPAN6 TMEM138 RYR2 KCNH3 CHST3 | 2.58e-04 | 1076 | 56 | 13 | MP:0021009 |
| MousePheno | abnormal muscle electrophysiology | 2.78e-04 | 32 | 56 | 3 | MP:0004145 | |
| MousePheno | abnormal channel response | 3.05e-04 | 33 | 56 | 3 | MP:0003484 | |
| MousePheno | pancreatic acinar cell zymogen granule accumulation | 3.27e-04 | 7 | 56 | 2 | MP:0009161 | |
| MousePheno | ventricular fibrillation | 3.27e-04 | 7 | 56 | 2 | MP:0006110 | |
| MousePheno | abnormal pancreatic alpha cell number | 3.64e-04 | 35 | 56 | 3 | MP:0020577 | |
| MousePheno | abnormal drinking behavior | 4.28e-04 | 159 | 56 | 5 | MP:0001422 | |
| MousePheno | abnormal CNS synaptic transmission | CACNA1A CACNA1B CACNA1C SLC9A9 KALRN DHCR7 IQSEC2 TSPAN6 TMEM138 RYR2 KCNH3 CHST3 | 4.33e-04 | 985 | 56 | 12 | MP:0002206 |
| MousePheno | thick ventricular wall | 4.77e-04 | 91 | 56 | 4 | MP:0002953 | |
| MousePheno | abnormal circulating glucagon level | 5.42e-04 | 40 | 56 | 3 | MP:0002695 | |
| MousePheno | abnormal myocardial fiber currents | 5.57e-04 | 9 | 56 | 2 | MP:0020345 | |
| MousePheno | asthenozoospermia | 5.74e-04 | 362 | 56 | 7 | MP:0002675 | |
| MousePheno | abnormal pancreatic acinar cell morphology | 5.83e-04 | 41 | 56 | 3 | MP:0009146 | |
| MousePheno | abnormal social investigation | 5.96e-04 | 171 | 56 | 5 | MP:0001360 | |
| MousePheno | abnormal pH regulation | 6.26e-04 | 42 | 56 | 3 | MP:0004043 | |
| MousePheno | abnormal pancreatic acinus morphology | 6.71e-04 | 43 | 56 | 3 | MP:0009145 | |
| MousePheno | abnormal excitatory postsynaptic potential | 7.33e-04 | 102 | 56 | 4 | MP:0002912 | |
| MousePheno | decreased vocalization | 8.18e-04 | 46 | 56 | 3 | MP:0020351 | |
| MousePheno | abnormal pancreatic alpha cell morphology | 8.18e-04 | 46 | 56 | 3 | MP:0005216 | |
| MousePheno | impaired social transmission of food preference | 8.47e-04 | 11 | 56 | 2 | MP:0002969 | |
| MousePheno | abnormal fear/anxiety-related behavior | CACNA1A CACNA1B CACNA1C CACNA1E KALRN IQSEC2 ATP13A3 OR5AR1 CRHR1 CRHR2 ITPR3 | 9.04e-04 | 919 | 56 | 11 | MP:0002065 |
| MousePheno | decreased physiological sensitivity to xenobiotic | 9.07e-04 | 283 | 56 | 6 | MP:0008874 | |
| MousePheno | abnormal sperm motility | 1.05e-03 | 401 | 56 | 7 | MP:0002674 | |
| Domain | Ion_trans_dom | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPTE SLC9C1 CATSPER2 CATSPER4 SCN3A SCN5A HVCN1 RYR1 RYR2 KCNH3 ITPR3 | 3.95e-23 | 114 | 70 | 17 | IPR005821 |
| Domain | Ion_trans | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TPTE SLC9C1 CATSPER2 CATSPER4 SCN3A SCN5A HVCN1 RYR1 RYR2 KCNH3 ITPR3 | 3.95e-23 | 114 | 70 | 17 | PF00520 |
| Domain | Channel_four-helix_dom | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F CATSPER2 CATSPER4 SCN3A SCN5A HVCN1 | 1.45e-16 | 57 | 70 | 11 | IPR027359 |
| Domain | - | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F CATSPER2 CATSPER4 SCN3A SCN5A HVCN1 | 1.45e-16 | 57 | 70 | 11 | 1.20.120.350 |
| Domain | VDCC_a1su_IQ | 1.55e-14 | 7 | 70 | 6 | IPR014873 | |
| Domain | GPHH | 1.55e-14 | 7 | 70 | 6 | PF16905 | |
| Domain | GPHH_dom | 1.55e-14 | 7 | 70 | 6 | IPR031649 | |
| Domain | Ca_chan_IQ | 1.55e-14 | 7 | 70 | 6 | SM01062 | |
| Domain | Ca_chan_IQ | 1.55e-14 | 7 | 70 | 6 | PF08763 | |
| Domain | VDCCAlpha1 | 4.62e-13 | 10 | 70 | 6 | IPR002077 | |
| Domain | CAC1F_C | 5.04e-08 | 3 | 70 | 3 | IPR031688 | |
| Domain | CAC1F_C | 5.04e-08 | 3 | 70 | 3 | PF16885 | |
| Domain | VDCC_L_a1su | 2.01e-07 | 4 | 70 | 3 | IPR005446 | |
| Domain | RIH_assoc | 1.00e-06 | 6 | 70 | 3 | PF08454 | |
| Domain | RIH_assoc-dom | 1.00e-06 | 6 | 70 | 3 | IPR013662 | |
| Domain | RIH_dom | 1.00e-06 | 6 | 70 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.00e-06 | 6 | 70 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.00e-06 | 6 | 70 | 3 | IPR015925 | |
| Domain | - | 1.00e-06 | 6 | 70 | 3 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.00e-06 | 6 | 70 | 3 | PF01365 | |
| Domain | Ins145_P3_rec | 1.00e-06 | 6 | 70 | 3 | PF08709 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 1.19e-06 | 50 | 70 | 5 | PS00650 | |
| Domain | 7tm_2 | 1.19e-06 | 50 | 70 | 5 | PF00002 | |
| Domain | HormR | 2.16e-06 | 25 | 70 | 4 | SM00008 | |
| Domain | GPCR_2_secretin-like | 2.98e-06 | 60 | 70 | 5 | IPR000832 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 3.23e-06 | 61 | 70 | 5 | PS50261 | |
| Domain | HRM | 3.46e-06 | 28 | 70 | 4 | PF02793 | |
| Domain | MIR | 5.94e-06 | 10 | 70 | 3 | PS50919 | |
| Domain | MIR | 5.94e-06 | 10 | 70 | 3 | PF02815 | |
| Domain | MIR | 5.94e-06 | 10 | 70 | 3 | SM00472 | |
| Domain | MIR_motif | 5.94e-06 | 10 | 70 | 3 | IPR016093 | |
| Domain | GPCR_2_secretin-like_CS | 7.71e-06 | 34 | 70 | 4 | IPR017983 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 1.49e-05 | 40 | 70 | 4 | PS00649 | |
| Domain | GPCR_2_extracellular_dom | 1.49e-05 | 40 | 70 | 4 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 1.49e-05 | 40 | 70 | 4 | PS50227 | |
| Domain | Ryanrecept_TM4-6 | 4.14e-05 | 3 | 70 | 2 | IPR009460 | |
| Domain | RyR | 4.14e-05 | 3 | 70 | 2 | PF02026 | |
| Domain | GPCR_2_CRF_rcpt | 4.14e-05 | 3 | 70 | 2 | IPR003051 | |
| Domain | Ryanodine_rcpt | 4.14e-05 | 3 | 70 | 2 | IPR003032 | |
| Domain | RR_TM4-6 | 4.14e-05 | 3 | 70 | 2 | PF06459 | |
| Domain | Ryan_recept | 4.14e-05 | 3 | 70 | 2 | IPR013333 | |
| Domain | GPCR_2-like | 7.53e-05 | 60 | 70 | 4 | IPR017981 | |
| Domain | Na_trans_cytopl | 2.06e-04 | 6 | 70 | 2 | PF11933 | |
| Domain | Na_trans_cytopl | 2.06e-04 | 6 | 70 | 2 | IPR024583 | |
| Domain | Na_channel_asu | 6.11e-04 | 10 | 70 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 6.11e-04 | 10 | 70 | 2 | IPR010526 | |
| Domain | Na_trans_assoc | 6.11e-04 | 10 | 70 | 2 | PF06512 | |
| Domain | Olfact_rcpt | 6.64e-04 | 393 | 70 | 7 | IPR000725 | |
| Domain | EF-hand-dom_pair | 7.19e-04 | 287 | 70 | 6 | IPR011992 | |
| Domain | Cation/H_exchanger_CPA1 | 7.45e-04 | 11 | 70 | 2 | IPR018422 | |
| Domain | GPCR_Rhodpsn_7TM | 8.59e-04 | 670 | 70 | 9 | IPR017452 | |
| Domain | 7tm_1 | 9.24e-04 | 677 | 70 | 9 | PF00001 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 1.00e-03 | 685 | 70 | 9 | PS00237 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 1.07e-03 | 691 | 70 | 9 | PS50262 | |
| Domain | GPCR_Rhodpsn | 1.08e-03 | 692 | 70 | 9 | IPR000276 | |
| Domain | Na_H_Exchanger | 1.22e-03 | 14 | 70 | 2 | PF00999 | |
| Domain | Cation/H_exchanger | 1.22e-03 | 14 | 70 | 2 | IPR006153 | |
| Domain | Tetraspanin_CS | 2.78e-03 | 21 | 70 | 2 | IPR018503 | |
| Domain | TM4_1 | 4.25e-03 | 26 | 70 | 2 | PS00421 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.88e-12 | 11 | 59 | 6 | M47958 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 3.95e-10 | 23 | 59 | 6 | M47666 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 6.89e-10 | 25 | 59 | 6 | M47948 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F PTAFR RYR1 RYR2 ITPR3 | 2.94e-09 | 178 | 59 | 10 | M2890 |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 4.12e-09 | 6 | 59 | 4 | M47762 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.63e-07 | 147 | 59 | 8 | MM15854 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 2.01e-07 | 151 | 59 | 8 | M39329 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 5.22e-07 | 72 | 59 | 6 | MM14631 | |
| Pathway | KEGG_TYPE_II_DIABETES_MELLITUS | 1.45e-06 | 47 | 59 | 5 | M19708 | |
| Pathway | KEGG_TASTE_TRANSDUCTION | 2.42e-06 | 52 | 59 | 5 | M5785 | |
| Pathway | WP_GPCRS_CLASS_B_SECRETINLIKE | 2.76e-06 | 24 | 59 | 4 | M39643 | |
| Pathway | WP_GPCRS_CLASS_B_SECRETINLIKE | 2.76e-06 | 24 | 59 | 4 | MM15992 | |
| Pathway | REACTOME_FERTILIZATION | 3.86e-06 | 26 | 59 | 4 | M26922 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 5.37e-06 | 61 | 59 | 5 | MM15071 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 5.70e-06 | 108 | 59 | 6 | M17034 | |
| Pathway | REACTOME_SPERM_MOTILITY_AND_TAXES | 5.75e-06 | 9 | 59 | 3 | M26935 | |
| Pathway | REACTOME_SPERM_MOTILITY_AND_TAXES | 5.75e-06 | 9 | 59 | 3 | MM14548 | |
| Pathway | REACTOME_REPRODUCTION | 6.99e-06 | 30 | 59 | 4 | MM17211 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | CACNA1D TAS2R1 OR4C3 OR6B3 OR6N2 OR6C1 SCN3A SCNN1G OR5AR1 OR6B2 ITPR3 OR52J3 | 1.02e-05 | 636 | 59 | 12 | M41834 |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 1.12e-05 | 11 | 59 | 3 | MM14498 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 1.12e-05 | 11 | 59 | 3 | M26913 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 1.65e-05 | 130 | 59 | 6 | M27454 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 1.81e-05 | 78 | 59 | 5 | M1921 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004 | 2.45e-05 | 14 | 59 | 3 | M47692 | |
| Pathway | REACTOME_SENSORY_PERCEPTION_OF_TASTE | 4.32e-05 | 47 | 59 | 4 | M42524 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 6.43e-05 | 19 | 59 | 3 | M47760 | |
| Pathway | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | 1.13e-04 | 60 | 59 | 4 | MM14964 | |
| Pathway | WP_GPCRS_NONODORANT | 1.16e-04 | 266 | 59 | 7 | MM15843 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 1.98e-04 | 203 | 59 | 6 | M5485 | |
| Pathway | KEGG_LONG_TERM_DEPRESSION | 2.07e-04 | 70 | 59 | 4 | M8232 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 2.56e-04 | 74 | 59 | 4 | M39462 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 2.56e-04 | 74 | 59 | 4 | M16376 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 2.56e-04 | 74 | 59 | 4 | MM15962 | |
| Pathway | REACTOME_SENSORY_PERCEPTION_OF_TASTE | 2.88e-04 | 31 | 59 | 3 | MM15691 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 3.17e-04 | 32 | 59 | 3 | M27455 | |
| Pathway | KEGG_CARDIAC_MUSCLE_CONTRACTION | 3.29e-04 | 79 | 59 | 4 | M17673 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 3.97e-04 | 83 | 59 | 4 | M8728 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 5.41e-04 | 90 | 59 | 4 | M835 | |
| Pathway | WP_MAPK_SIGNALING | 5.52e-04 | 246 | 59 | 6 | M39597 | |
| Pathway | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | 6.37e-04 | 94 | 59 | 4 | M797 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 7.12e-04 | 42 | 59 | 3 | M7169 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 8.35e-04 | 101 | 59 | 4 | M1979 | |
| Pathway | KEGG_MAPK_SIGNALING_PATHWAY | 8.48e-04 | 267 | 59 | 6 | M10792 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 8.99e-04 | 103 | 59 | 4 | MM15196 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 9.91e-04 | 183 | 59 | 5 | M997 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 1.00e-03 | 106 | 59 | 4 | M27200 | |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | 1.14e-03 | 389 | 59 | 7 | M14091 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 1.30e-03 | 13 | 59 | 2 | M39589 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 1.35e-03 | 115 | 59 | 4 | M9387 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.48e-03 | 54 | 59 | 3 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.48e-03 | 54 | 59 | 3 | MM15202 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 1.71e-03 | 417 | 59 | 7 | M4072 | |
| Pathway | WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION | 1.99e-03 | 16 | 59 | 2 | M40060 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 2.31e-03 | 63 | 59 | 3 | M11187 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 3.00e-03 | 143 | 59 | 4 | MM15055 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 3.30e-03 | 736 | 59 | 9 | M27287 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CARDIAC_TYPE_VGCC_RYR_SIGNALING | 3.44e-03 | 21 | 59 | 2 | M47950 | |
| Pathway | WP_DRAVET_SYNDROME_SCN1AA1783V_POINT_MUTATION_MODEL | 3.52e-03 | 73 | 59 | 3 | MM16641 | |
| Pathway | WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY | 3.66e-03 | 74 | 59 | 3 | M48080 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 3.91e-03 | 154 | 59 | 4 | MM15974 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 4.10e-03 | 156 | 59 | 4 | M39475 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 4.19e-03 | 157 | 59 | 4 | M4904 | |
| Pathway | REACTOME_REPRODUCTION | 4.28e-03 | 158 | 59 | 4 | M26956 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 5.00e-03 | 165 | 59 | 4 | MM15026 | |
| Pathway | KEGG_ALZHEIMERS_DISEASE | 5.10e-03 | 166 | 59 | 4 | M16024 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | 5.23e-03 | 646 | 59 | 8 | MM14962 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 5.52e-03 | 272 | 59 | 5 | M13380 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F RYR1 RYR2 ITPR3 | 6.46e-17 | 38 | 72 | 9 | 30786075 |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F SCN3A SCN5A SCNN1G RYR2 KCNH3 | 6.82e-15 | 139 | 72 | 11 | 16985003 |
| Pubmed | 3.30e-14 | 5 | 72 | 5 | 11296258 | ||
| Pubmed | 3.30e-14 | 5 | 72 | 5 | 15451373 | ||
| Pubmed | 3.14e-13 | 15 | 72 | 6 | 20188150 | ||
| Pubmed | 3.14e-13 | 15 | 72 | 6 | 24453333 | ||
| Pubmed | 4.13e-12 | 9 | 72 | 5 | 16382099 | ||
| Pubmed | 5.88e-10 | 7 | 72 | 4 | 12900400 | ||
| Pubmed | 1.17e-09 | 8 | 72 | 4 | 28330839 | ||
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 38996073 | ||
| Pubmed | Molecular Basis of Regulating High Voltage-Activated Calcium Channels by S-Nitrosylation. | 8.51e-09 | 3 | 72 | 3 | 26507659 | |
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 23338940 | ||
| Pubmed | Distinct roles for Cav2.1-2.3 in activity-dependent synaptic dynamics. | 8.51e-09 | 3 | 72 | 3 | 24523520 | |
| Pubmed | 2.02e-08 | 143 | 72 | 7 | 20424473 | ||
| Pubmed | 3.40e-08 | 4 | 72 | 3 | 20937870 | ||
| Pubmed | Cerebellar granule cell signaling is indispensable for normal motor performance. | 3.40e-08 | 4 | 72 | 3 | 37141091 | |
| Pubmed | Synapse and Active Zone Assembly in the Absence of Presynaptic Ca2+ Channels and Ca2+ Entry. | 3.40e-08 | 4 | 72 | 3 | 32616470 | |
| Pubmed | 3.40e-08 | 4 | 72 | 3 | 15728831 | ||
| Pubmed | 3.40e-08 | 4 | 72 | 3 | 31253182 | ||
| Pubmed | G protein-gated inhibitory module of N-type (ca(v)2.2) ca2+ channels. | 3.40e-08 | 4 | 72 | 3 | 15953418 | |
| Pubmed | 8.48e-08 | 5 | 72 | 3 | 8825650 | ||
| Pubmed | 8.48e-08 | 5 | 72 | 3 | 16787652 | ||
| Pubmed | 8.48e-08 | 5 | 72 | 3 | 31663850 | ||
| Pubmed | Voltage-gated calcium channels in developing GnRH-1 neuronal system in the mouse. | 1.69e-07 | 6 | 72 | 3 | 16029198 | |
| Pubmed | 1.69e-07 | 6 | 72 | 3 | 23463619 | ||
| Pubmed | An action potential initiation mechanism in distal axons for the control of dopamine release. | 1.69e-07 | 6 | 72 | 3 | 35324301 | |
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 1.69e-07 | 6 | 72 | 3 | 25966694 | |
| Pubmed | Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. | 1.69e-07 | 6 | 72 | 3 | 12827191 | |
| Pubmed | 1.69e-07 | 6 | 72 | 3 | 20519450 | ||
| Pubmed | 1.69e-07 | 6 | 72 | 3 | 16352659 | ||
| Pubmed | 1.69e-07 | 6 | 72 | 3 | 9238069 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 1.69e-07 | 6 | 72 | 3 | 16844763 | |
| Pubmed | 2.96e-07 | 7 | 72 | 3 | 11860456 | ||
| Pubmed | Rebuilding essential active zone functions within a synapse. | 2.96e-07 | 7 | 72 | 3 | 35176221 | |
| Pubmed | 4.73e-07 | 8 | 72 | 3 | 11784029 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 4.73e-07 | 8 | 72 | 3 | 19033399 | |
| Pubmed | 1.01e-06 | 10 | 72 | 3 | 26897459 | ||
| Pubmed | 1.39e-06 | 11 | 72 | 3 | 17903301 | ||
| Pubmed | 1.39e-06 | 11 | 72 | 3 | 18809727 | ||
| Pubmed | 1.85e-06 | 12 | 72 | 3 | 19095005 | ||
| Pubmed | 2.40e-06 | 13 | 72 | 3 | 28727763 | ||
| Pubmed | 2.40e-06 | 13 | 72 | 3 | 15123669 | ||
| Pubmed | MED12 regulates a transcriptional network of calcium-handling genes in the heart. | 3.05e-06 | 14 | 72 | 3 | 28724790 | |
| Pubmed | Molecular mechanisms of corticotropin-releasing factor receptor-induced calcium signaling. | 4.23e-06 | 2 | 72 | 2 | 19098121 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 23723061 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 15610184 | ||
| Pubmed | Stable respiratory activity requires both P/Q-type and N-type voltage-gated calcium channels. | 4.23e-06 | 2 | 72 | 2 | 23426690 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 37543650 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 21054386 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 17259277 | ||
| Pubmed | Ryanodine receptor oligomeric interaction: identification of a putative binding region. | 4.23e-06 | 2 | 72 | 2 | 14722100 | |
| Pubmed | Structural and functional interactions within ryanodine receptor. | 4.23e-06 | 2 | 72 | 2 | 26009179 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 27418245 | ||
| Pubmed | Voltage-Gated Cav1 Channels in Disorders of Vision and Hearing. | 4.23e-06 | 2 | 72 | 2 | 25966695 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 14724656 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 32899693 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 23376566 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 24086669 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 17959885 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 18325997 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 32057826 | ||
| Pubmed | Differential zinc permeation and blockade of L-type Ca2+ channel isoforms Cav1.2 and Cav1.3. | 4.23e-06 | 2 | 72 | 2 | 26049024 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 18586264 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 19225208 | ||
| Pubmed | Ca1.2 and CaV1.3 neuronal L-type calcium channels: differential targeting and signaling to pCREB. | 4.23e-06 | 2 | 72 | 2 | 16706838 | |
| Pubmed | Effect of CRHR1 and CRHR2 gene polymorphisms and childhood trauma in suicide attempt. | 4.23e-06 | 2 | 72 | 2 | 30874897 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 23761887 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 14981074 | ||
| Pubmed | CaV1.2 and CaV1.3 channel hyperactivation in mouse islet β cells exposed to type 1 diabetic serum. | 4.23e-06 | 2 | 72 | 2 | 25292336 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 38155373 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 17526649 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 12606379 | ||
| Pubmed | Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators. | 4.23e-06 | 2 | 72 | 2 | 24941892 | |
| Pubmed | Complex Brugada syndrome inheritance in a family harbouring compound SCN5A and CACNA1C mutations. | 4.23e-06 | 2 | 72 | 2 | 25341504 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 22826131 | ||
| Pubmed | C-terminal modulator controls Ca2+-dependent gating of Ca(v)1.4 L-type Ca2+ channels. | 4.23e-06 | 2 | 72 | 2 | 16921373 | |
| Pubmed | Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion. | 4.23e-06 | 2 | 72 | 2 | 15033925 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 24470632 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 12548396 | ||
| Pubmed | Corticotropin-Releasing Hormone Family and Their Receptors in the Cardiovascular System. | 4.23e-06 | 2 | 72 | 2 | 30584229 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 24760982 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 23821771 | ||
| Pubmed | Purkinje Cells as Sources of Arrhythmias in Long QT Syndrome Type 3. | 4.23e-06 | 2 | 72 | 2 | 26289036 | |
| Pubmed | Maurocalcin and its analog MCaE12A facilitate Ca2+ mobilization in cardiomyocytes. | 4.23e-06 | 2 | 72 | 2 | 33034621 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 20014384 | ||
| Pubmed | Expression and subcellular localization of CRH and its receptors in human endometrial cancer. | 4.23e-06 | 2 | 72 | 2 | 19433256 | |
| Pubmed | L-type calcium channels contribute to the tottering mouse dystonic episodes. | 4.23e-06 | 2 | 72 | 2 | 9882694 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 12973680 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 30001160 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 20594969 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 16381801 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 21352396 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 22467522 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 15932895 | ||
| Pubmed | Molecular nature of anomalous L-type calcium channels in mouse cerebellar granule cells. | 4.23e-06 | 2 | 72 | 2 | 17409250 | |
| Pubmed | Neuronal L-type calcium channels open quickly and are inhibited slowly. | 4.23e-06 | 2 | 72 | 2 | 16267232 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 24996399 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 31844086 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 17170072 | ||
| Pubmed | Genetic analysis in post-mortem samples with micro-ischemic alterations. | 4.23e-06 | 2 | 72 | 2 | 28086167 | |
| Interaction | CACNA1D interactions | 1.14e-10 | 24 | 65 | 6 | int:CACNA1D | |
| Interaction | SCN11A interactions | 8.74e-10 | 15 | 65 | 5 | int:SCN11A | |
| Interaction | CACNA1B interactions | 1.91e-09 | 37 | 65 | 6 | int:CACNA1B | |
| Interaction | SCN9A interactions | 5.83e-09 | 21 | 65 | 5 | int:SCN9A | |
| Interaction | SCN1A interactions | 3.34e-08 | 29 | 65 | 5 | int:SCN1A | |
| Interaction | CACNA1C interactions | 4.30e-08 | 61 | 65 | 6 | int:CACNA1C | |
| Interaction | NALCN interactions | 9.63e-08 | 14 | 65 | 4 | int:NALCN | |
| Interaction | CACNA1A interactions | 1.38e-07 | 123 | 65 | 7 | int:CACNA1A | |
| Interaction | SCN5A interactions | 4.12e-07 | 47 | 65 | 5 | int:SCN5A | |
| Interaction | CACNB2 interactions | 8.33e-07 | 23 | 65 | 4 | int:CACNB2 | |
| Interaction | RYR2 interactions | 1.20e-06 | 58 | 65 | 5 | int:RYR2 | |
| Interaction | SCN10A interactions | 5.19e-06 | 11 | 65 | 3 | int:SCN10A | |
| Interaction | CABP1 interactions | 1.42e-05 | 15 | 65 | 3 | int:CABP1 | |
| Interaction | RAB5C interactions | SLC9A9 WDR7 SLC38A9 DHCR7 CFTR TMPO ATP13A3 RFT1 VAMP8 ITPR3 | 2.08e-05 | 600 | 65 | 10 | int:RAB5C |
| Interaction | AKAP6 interactions | 2.11e-05 | 17 | 65 | 3 | int:AKAP6 | |
| Interaction | UCN3 interactions | 5.42e-05 | 23 | 65 | 3 | int:UCN3 | |
| Interaction | CACNB4 interactions | 7.00e-05 | 25 | 65 | 3 | int:CACNB4 | |
| Interaction | TCTN3 interactions | 9.85e-05 | 334 | 65 | 7 | int:TCTN3 | |
| Interaction | CACNB3 interactions | 1.49e-04 | 32 | 65 | 3 | int:CACNB3 | |
| Interaction | UCN interactions | 1.52e-04 | 6 | 65 | 2 | int:UCN | |
| Interaction | CALM1 interactions | 1.72e-04 | 626 | 65 | 9 | int:CALM1 | |
| Interaction | FADS1 interactions | 1.79e-04 | 87 | 65 | 4 | int:FADS1 | |
| Interaction | SORCS1 interactions | 2.13e-04 | 7 | 65 | 2 | int:SORCS1 | |
| GeneFamily | Calcium voltage-gated channel subunits | 2.77e-10 | 26 | 62 | 6 | 253 | |
| GeneFamily | Corticotropin releasing hormone receptors | 1.16e-05 | 2 | 62 | 2 | 266 | |
| GeneFamily | Olfactory receptors, family 6 | 2.78e-05 | 51 | 62 | 4 | 153 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 3.46e-05 | 3 | 62 | 2 | 287 | |
| GeneFamily | Cation channels sperm associated | 2.40e-04 | 7 | 62 | 2 | 186 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 4.10e-04 | 9 | 62 | 2 | 1203 | |
| GeneFamily | CD molecules|Tetraspanins | 5.71e-03 | 33 | 62 | 2 | 768 | |
| Coexpression | WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN | 5.63e-06 | 43 | 71 | 4 | M16646 | |
| Coexpression | WEBER_METHYLATED_HCP_IN_SPERM_UP | 2.10e-05 | 20 | 71 | 3 | M1506 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_500 | 9.44e-06 | 41 | 69 | 4 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k4_500 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.42e-08 | 189 | 72 | 7 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.60e-08 | 191 | 72 | 7 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.69e-08 | 192 | 72 | 7 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.69e-08 | 192 | 72 | 7 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.89e-08 | 194 | 72 | 7 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.89e-08 | 194 | 72 | 7 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.32e-08 | 198 | 72 | 7 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.32e-08 | 198 | 72 | 7 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.32e-08 | 198 | 72 | 7 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.32e-08 | 198 | 72 | 7 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.32e-08 | 198 | 72 | 7 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 3.56e-08 | 200 | 72 | 7 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.56e-08 | 200 | 72 | 7 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.56e-08 | 200 | 72 | 7 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.89e-07 | 181 | 72 | 6 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.38e-07 | 184 | 72 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.38e-07 | 184 | 72 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.38e-07 | 184 | 72 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 5.92e-07 | 187 | 72 | 6 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.30e-07 | 189 | 72 | 6 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 6.50e-07 | 190 | 72 | 6 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.50e-07 | 190 | 72 | 6 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.70e-07 | 191 | 72 | 6 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.90e-07 | 192 | 72 | 6 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.90e-07 | 192 | 72 | 6 | f14ee74ac3275601749a23c5efe39c2413a62e1a | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.90e-07 | 192 | 72 | 6 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.90e-07 | 192 | 72 | 6 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.90e-07 | 192 | 72 | 6 | 0219093e7921a0db78053aee13ec480b520f5662 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-07 | 193 | 72 | 6 | 461919ab422bc9d1fcff7a3a4757c75239041d7e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-07 | 193 | 72 | 6 | 0dd810ad900d3e586551622b2c1de39d76fd6a7f | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.12e-07 | 193 | 72 | 6 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.12e-07 | 193 | 72 | 6 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 7.12e-07 | 193 | 72 | 6 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.12e-07 | 193 | 72 | 6 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 7.12e-07 | 193 | 72 | 6 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.34e-07 | 194 | 72 | 6 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.34e-07 | 194 | 72 | 6 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.34e-07 | 194 | 72 | 6 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.34e-07 | 194 | 72 | 6 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.56e-07 | 195 | 72 | 6 | ffbab350e67d9c4b66c0ab84550daec8b8139a27 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 7.56e-07 | 195 | 72 | 6 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 7.56e-07 | 195 | 72 | 6 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 7.56e-07 | 195 | 72 | 6 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.79e-07 | 196 | 72 | 6 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.79e-07 | 196 | 72 | 6 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.79e-07 | 196 | 72 | 6 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.79e-07 | 196 | 72 | 6 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.02e-07 | 197 | 72 | 6 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.02e-07 | 197 | 72 | 6 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.02e-07 | 197 | 72 | 6 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.02e-07 | 197 | 72 | 6 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.26e-07 | 198 | 72 | 6 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.26e-07 | 198 | 72 | 6 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.26e-07 | 198 | 72 | 6 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.26e-07 | 198 | 72 | 6 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 8.51e-07 | 199 | 72 | 6 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.51e-07 | 199 | 72 | 6 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.76e-07 | 200 | 72 | 6 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.76e-07 | 200 | 72 | 6 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 8.76e-07 | 200 | 72 | 6 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.76e-07 | 200 | 72 | 6 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.76e-07 | 200 | 72 | 6 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.76e-07 | 200 | 72 | 6 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.76e-07 | 200 | 72 | 6 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT1_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.99e-06 | 138 | 72 | 5 | 615822e542f12aa83df1561e262b8d72bdefc60e | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-leukocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.96e-06 | 153 | 72 | 5 | 8cc2667213bfac37545bb63181e88ef1f1834413 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-leukocyte-proliferating_myeloid_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.96e-06 | 153 | 72 | 5 | 596bb7cfd1c713708ce73df30d890a0233eae7f7 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 5.98e-06 | 159 | 72 | 5 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | facs-Lung-EPCAM-18m-Hematologic-Proliferating_Immune|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.17e-06 | 160 | 72 | 5 | 7217730ae14840b935b3bf9aa49becbcbcd8a682 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 6.17e-06 | 160 | 72 | 5 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | facs-Lung-EPCAM-18m-Hematologic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.17e-06 | 160 | 72 | 5 | 317ef81460c1a31b51119a6309b11be6a8d4ea3e | |
| ToppCell | facs-Lung-EPCAM-18m-Hematologic-leukocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.17e-06 | 160 | 72 | 5 | e6191240c93da34fc4431a35ef496edf323cb41e | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 6.36e-06 | 161 | 72 | 5 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | control-Epithelial-Ionocyte|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.16e-06 | 165 | 72 | 5 | 5cfba9a46bd8ceeca74a6493057b4d38af6b06fe | |
| ToppCell | PCW_07-8.5-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_mast/basophil_(18)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.37e-06 | 166 | 72 | 5 | f03f78cae6272c89618c0bda032ce45c4fc96baa | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.59e-06 | 167 | 72 | 5 | 8b223333c0c7a85b5a1af6f2f5b12ee0d94357f6 | |
| ToppCell | control-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.82e-06 | 168 | 72 | 5 | 327b02f19f4a8607c033203824fdc60a1254331f | |
| ToppCell | facs-Kidney-nan-18m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.76e-06 | 172 | 72 | 5 | bc1b889ac5e07b8324ae5837eca911f9c865e959 | |
| ToppCell | facs-Kidney-nan-18m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.76e-06 | 172 | 72 | 5 | ba70b6110b70afb1870e8dcaf58c507b8c7d918e | |
| ToppCell | COVID-19-kidney-CD-IC-A|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.79e-06 | 176 | 72 | 5 | 45028197364c64e93e3ffe86aff773d47a477d49 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.09e-05 | 180 | 72 | 5 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.09e-05 | 180 | 72 | 5 | 5286e66ff6b7154390b3e9c189704a71d56bc89c | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.09e-05 | 180 | 72 | 5 | 2b6b295b5c21b829828afae9ab4c3eb9233f6f45 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.09e-05 | 180 | 72 | 5 | bf587387145a2b5e83766fbccf76eecc6d5e8241 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|Epithelial / Condition, Lineage and Cell class | 1.12e-05 | 181 | 72 | 5 | 4a8d4f2709c1b25f908867f1b2fae1d2d0abf1d4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-05 | 181 | 72 | 5 | 22363c5835dd6cef8f895ab9362e0837d92b15b1 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 1.18e-05 | 183 | 72 | 5 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.18e-05 | 183 | 72 | 5 | 4763df29c888d47c22076803b054f06b4cc29368 | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.18e-05 | 183 | 72 | 5 | fcb0f755382d88fb207fc2322cd224c09c6e2ea6 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.18e-05 | 183 | 72 | 5 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | critical-Epithelial-Ionocyte|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.21e-05 | 184 | 72 | 5 | 58d36577eff814d46d72f031f3533d71549e3d6e | |
| ToppCell | PND01-03-samps-Epithelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.25e-05 | 185 | 72 | 5 | 2b854df79cfe2cb4d2f9c2938a066e0aa3649325 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.25e-05 | 185 | 72 | 5 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-05 | 186 | 72 | 5 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | PND01-03-samps-Epithelial-Alveolar_epithelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.31e-05 | 187 | 72 | 5 | 23fe3cdd6cc9b067086a8392d104186d300298ea | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.31e-05 | 187 | 72 | 5 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.35e-05 | 188 | 72 | 5 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 188 | 72 | 5 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 188 | 72 | 5 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | COVID-19-Epithelial-Ionocytes|COVID-19 / Condition, Lineage and Cell class | 1.35e-05 | 188 | 72 | 5 | a581cb9528d0febbf3addbb4f6bc140f91a584e6 | |
| Computational | Ion channels. | 1.68e-04 | 70 | 43 | 4 | MODULE_316 | |
| Drug | Cinildipine | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F CALCR CRTAM RYR1 RYR2 ITPR3 | 1.61e-17 | 56 | 71 | 11 | CID000002752 |
| Drug | lamotrigine | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F SCN3A SCN5A SCNN1G GRINA RYR1 RYR2 ITPR3 | 3.54e-17 | 116 | 71 | 13 | CID000003878 |
| Drug | CNS 1145 | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F RYR1 RYR2 ITPR3 | 5.99e-16 | 33 | 71 | 9 | CID000190902 |
| Drug | IHC-64 | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F RYR1 RYR2 ITPR3 | 5.99e-16 | 33 | 71 | 9 | CID000162753 |
| Drug | IAA-94 | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F CFTR RYR1 RYR2 ITPR3 | 3.57e-15 | 61 | 71 | 10 | CID000003667 |
| Drug | bepridil | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F SCN3A SCN5A SCNN1G RYR1 RYR2 ITPR3 | 4.69e-15 | 126 | 71 | 12 | CID000002351 |
| Drug | gabapentin | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F SCN3A SCN5A SCNN1G GRINA RYR1 RYR2 ITPR3 | 5.21e-15 | 169 | 71 | 13 | CID000003446 |
| Drug | riluzole | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F SCN3A SCN5A SCNN1G GRINA RYR1 RYR2 ITPR3 | 7.62e-15 | 174 | 71 | 13 | CID000005070 |
| Drug | NSC7524 | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F SCN3A SCN5A SCNN1G GRINA RYR1 RYR2 ITPR3 | 1.37e-14 | 182 | 71 | 13 | CID000005657 |
| Drug | isradipine | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F SCN3A SCNN1G RYR1 RYR2 ITPR3 | 1.37e-14 | 100 | 71 | 11 | CID000003784 |
| Drug | procaine | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F CFTR SCN3A SCNN1G RYR1 RYR2 ITPR3 | 4.99e-14 | 153 | 71 | 12 | CID000004914 |
| Drug | phenytoin | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F COL6A3 SCN3A SCN5A SCNN1G RYR1 RYR2 ITPR3 | 1.50e-13 | 219 | 71 | 13 | CID000001775 |
| Drug | nilvadipine | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F RYR1 RYR2 ITPR3 | 2.15e-13 | 60 | 71 | 9 | CID000004494 |
| Drug | lercanidipine | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F RYR1 RYR2 ITPR3 | 3.41e-13 | 63 | 71 | 9 | CID000065866 |
| Drug | gallopamil | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F RYR1 RYR2 ITPR3 | 6.10e-13 | 67 | 71 | 9 | CID000001234 |
| Drug | AC1L2AC7 | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F RYR1 RYR2 ITPR3 | 8.05e-13 | 69 | 71 | 9 | CID000068733 |
| Drug | CAS 298-57-7 | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F RYR1 RYR2 ITPR3 | 1.37e-12 | 73 | 71 | 9 | CID000002761 |
| Drug | ethosuximide | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F RYR1 RYR2 ITPR3 | 1.55e-12 | 74 | 71 | 9 | CID000003291 |
| Drug | verapamil | EPHB6 CACNA1A CACNA1B CYP1A1 CACNA1C CACNA1D CACNA1E CACNA1F ABCA6 CFTR SCN3A SCN5A SCNN1G RYR1 RYR2 ITPR3 | 1.79e-12 | 490 | 71 | 16 | CID000002520 |
| Drug | nisoldipine | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F RYR1 RYR2 ITPR3 | 2.53e-12 | 78 | 71 | 9 | CID000004499 |
| Drug | N-cyclopentyl-N-cyclobutylformamide | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F RYR1 RYR2 ITPR3 | 2.85e-12 | 79 | 71 | 9 | CID005287890 |
| Drug | felodipine | CACNA1A CACNA1B CYP1A1 CACNA1C CACNA1D CACNA1E CACNA1F CFTR RYR1 RYR2 ITPR3 | 4.73e-12 | 169 | 71 | 11 | CID000003333 |
| Drug | Verapamil | 5.79e-12 | 16 | 71 | 6 | DB00661 | |
| Drug | manidipine | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F RYR1 RYR2 ITPR3 | 1.57e-11 | 95 | 71 | 9 | CID000004008 |
| Drug | NSC759576 | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F GCGR AQP4 RYR1 RYR2 ITPR3 | 1.79e-11 | 191 | 71 | 11 | CID000003075 |
| Drug | isotetrandrine | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F RYR1 RYR2 ITPR3 | 1.90e-11 | 97 | 71 | 9 | CID000005422 |
| Drug | nitrendipine | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F RYR1 RYR2 ITPR3 | 2.08e-11 | 98 | 71 | 9 | CID000004507 |
| Drug | nimodipine | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F GRINA RYR1 RYR2 ITPR3 | 2.66e-11 | 145 | 71 | 10 | CID000004497 |
| Drug | Dantrolene-13C3 | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F GRINA RYR1 RYR2 ITPR3 | 2.66e-11 | 145 | 71 | 10 | CID000002951 |
| Drug | loperamide | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F RYR1 RYR2 ITPR3 | 3.91e-11 | 105 | 71 | 9 | CID000003954 |
| Drug | AC1NBU2S | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F RYR1 RYR2 ITPR3 | 1.04e-10 | 117 | 71 | 9 | CID004473765 |
| Drug | AC1L1DXE | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F WDR7 CFTR GRINA RYR1 RYR2 ITPR3 | 1.35e-10 | 299 | 71 | 12 | CID000002548 |
| Drug | lavendustin A | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F CFTR RYR1 RYR2 ITPR3 | 1.36e-10 | 171 | 71 | 10 | CID000003894 |
| Drug | papaverine | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F CFTR RYR1 RYR2 ITPR3 | 1.81e-10 | 176 | 71 | 10 | CID000004680 |
| Drug | pimozide | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F RYR1 RYR2 ITPR3 | 2.18e-10 | 127 | 71 | 9 | CID000016362 |
| Drug | aldosterone | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TAS2R1 DHCR7 CFTR SCNN1G RYR1 RYR2 ITPR3 | 2.64e-10 | 397 | 71 | 13 | CID000005839 |
| Drug | lanthanum | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F RYR1 RYR2 ITPR3 | 4.03e-10 | 136 | 71 | 9 | CID000023926 |
| Drug | baclofen | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F GRINA RYR1 RYR2 ITPR3 | 4.04e-10 | 191 | 71 | 10 | CID000002284 |
| Drug | dihydropyridine | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F SCNN1G RYR1 RYR2 ITPR3 | 4.47e-10 | 193 | 71 | 10 | CID000104822 |
| Drug | nicardipine | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F RYR1 RYR2 ITPR3 | 7.14e-10 | 145 | 71 | 9 | CID000004473 |
| Drug | Bay K 8644 | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F RYR1 RYR2 ITPR3 | 9.66e-10 | 150 | 71 | 9 | CID000002303 |
| Drug | potassium | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F SLC9A9 CFTR SCN3A ATP6V0A4 SCN5A SCNN1G GRINA AQP4 RYR1 RYR2 KCNH3 ITPR3 | 1.24e-09 | 1008 | 71 | 18 | CID000000813 |
| Drug | U46619 | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F TMPO PTAFR RYR1 RYR2 ITPR3 | 1.28e-09 | 285 | 71 | 11 | CID000005618 |
| Drug | AC1L1TJF | 1.42e-09 | 66 | 71 | 7 | CID000003377 | |
| Drug | Barium | 2.66e-09 | 72 | 71 | 7 | ctd:D001464 | |
| Drug | AC1L1KS5 | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F CRHR1 CRHR2 RYR1 RYR2 ITPR3 | 6.72e-09 | 334 | 71 | 11 | CID000005631 |
| Drug | cyclophorine | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F COL6A3 CD40 AQP4 RYR1 RYR2 ITPR3 | 7.46e-09 | 426 | 71 | 12 | CID000002909 |
| Drug | KW-3049 | 1.06e-08 | 50 | 71 | 6 | CID000002324 | |
| Drug | mercury | CACNA1A CACNA1B CYP1A1 CACNA1C CACNA1D CACNA1E CACNA1F CFTR CD40 AQP4 RYR1 RYR2 ITPR3 | 1.12e-08 | 542 | 71 | 13 | CID000023931 |
| Drug | gadolinium | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F RYR1 RYR2 ITPR3 | 1.16e-08 | 199 | 71 | 9 | CID000023982 |
| Drug | lindane | 2.71e-08 | 154 | 71 | 8 | CID000000727 | |
| Drug | ethanol | CACNA1B CYP1A1 CACNA1C CACNA1D CACNA1E CACNA1F SCN3A CD40 SCNN1G GCGR ACVR1B GRINA VAMP8 CRHR1 ITPR3 | 3.58e-08 | 837 | 71 | 15 | CID000000702 |
| Drug | Calcium | CACNA1A CACNA1B CYP1A1 CACNA1C CACNA1D CACNA1E CACNA1F CFTR PTAFR RYR1 RYR2 ITPR3 | 3.74e-08 | 493 | 71 | 12 | ctd:D002118 |
| Drug | 8-bromoguanosine 3',5'-cyclic monophosphate | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F CFTR RYR1 RYR2 ITPR3 | 3.95e-08 | 308 | 71 | 10 | CID000001915 |
| Drug | pyraclofos | 4.04e-08 | 106 | 71 | 7 | CID000093460 | |
| Drug | 3-(1H-pyrrole-2-carboxylate | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E SCN5A RYR1 RYR2 ITPR3 | 4.53e-08 | 233 | 71 | 9 | CID000005114 |
| Drug | halothane | CACNA1A CACNA1B CYP1A1 CACNA1C CACNA1D CACNA1E CACNA1F RYR1 RYR2 ITPR3 | 4.74e-08 | 314 | 71 | 10 | CID000003562 |
| Drug | mibefradil | 4.82e-08 | 64 | 71 | 6 | CID000060662 | |
| Drug | nifedipine | CACNA1A CACNA1B CYP1A1 CACNA1C CACNA1D CACNA1E CACNA1F GRINA RYR1 RYR2 ITPR3 | 6.21e-08 | 415 | 71 | 11 | CID000004485 |
| Drug | BAPTA | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CFTR GRINA RYR1 RYR2 ITPR3 | 6.35e-08 | 324 | 71 | 10 | CID000104751 |
| Drug | AC1L1JG6 | 8.49e-08 | 14 | 71 | 4 | CID000005026 | |
| Drug | flecainide | 9.05e-08 | 71 | 71 | 6 | CID000003355 | |
| Drug | propranolol | CACNA1A CACNA1B CYP1A1 CACNA1C CACNA1D CACNA1E CACNA1F SCN5A RYR1 RYR2 ITPR3 | 9.75e-08 | 434 | 71 | 11 | CID000004946 |
| Drug | fluo-3 | 1.07e-07 | 122 | 71 | 7 | CID000104978 | |
| Drug | butamben | 1.15e-07 | 15 | 71 | 4 | CID000002482 | |
| Drug | FPL 64176 | 1.15e-07 | 15 | 71 | 4 | CID000003423 | |
| Drug | AC 110 | 1.16e-07 | 4 | 71 | 3 | CID000022860 | |
| Drug | isoproterenol | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1F CFTR SCN3A SCN5A SCNN1G GCGR AQP4 RYR1 RYR2 | 1.31e-07 | 669 | 71 | 13 | CID000003779 |
| Drug | amlodipine | 1.33e-07 | 126 | 71 | 7 | CID000002162 | |
| Drug | caffeine | CACNA1A CACNA1B CYP1A1 CACNA1C CACNA1D CACNA1E CACNA1F TAS2R1 GRINA RYR1 RYR2 ITPR3 | 1.55e-07 | 562 | 71 | 12 | CID000002519 |
| Drug | guanosine 3',5'-cyclic monophosphoric acid | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F CFTR TMPO GRINA RYR1 RYR2 ITPR3 | 2.05e-07 | 577 | 71 | 12 | CID000000295 |
| Drug | glutamate | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F CFTR CD40 SCNN1G IFT122 GRINA AQP4 RYR1 RYR2 ITPR3 | 2.18e-07 | 962 | 71 | 15 | CID000000611 |
| Drug | gamma-aminobutyric acid | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F CFTR GRINA RYR1 RYR2 ITPR3 | 2.36e-07 | 474 | 71 | 11 | CID000000119 |
| Drug | Isradipine | 2.57e-07 | 18 | 71 | 4 | ctd:D017275 | |
| Drug | GTP[S] | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CFTR SCN3A SCNN1G GCGR CRHR1 RYR1 ITPR3 | 2.65e-07 | 591 | 71 | 12 | CID000001764 |
| Drug | valproate | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F SCNN1G RYR1 RYR2 ITPR3 | 2.85e-07 | 381 | 71 | 10 | CID000003121 |
| Drug | isovalerate | 3.16e-07 | 143 | 71 | 7 | CID000010430 | |
| Drug | pranidipine | 3.25e-07 | 19 | 71 | 4 | CID006436048 | |
| Drug | 3,4-dihydroquinazoline | 5.77e-07 | 6 | 71 | 3 | CID000583065 | |
| Drug | alpha-sialylcholesterol | 5.77e-07 | 6 | 71 | 3 | CID000133976 | |
| Drug | AC1L1GTT | 6.52e-07 | 233 | 71 | 8 | CID000003837 | |
| Drug | N-methyl-DL-aspartic acid | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F SCNN1G GRINA CRHR1 RYR1 RYR2 ITPR3 | 7.89e-07 | 655 | 71 | 12 | CID000004376 |
| Drug | Amlodipine | 1.01e-06 | 7 | 71 | 3 | DB00381 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 1.01e-06 | 7 | 71 | 3 | CID009547999 | |
| Drug | APMPA | 1.01e-06 | 7 | 71 | 3 | CID000512300 | |
| Drug | Br2BAPTA | 1.01e-06 | 7 | 71 | 3 | CID003081001 | |
| Drug | K-Cl | EPHB6 CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E SLC9A9 CFTR CD40 RYR1 RYR2 | 1.37e-06 | 567 | 71 | 11 | CID000004873 |
| Drug | 4-AP | 1.40e-06 | 258 | 71 | 8 | CID000001727 | |
| Drug | isobutanol | 1.44e-06 | 62 | 71 | 5 | CID000006560 | |
| Drug | EGTA-AM | 1.44e-06 | 62 | 71 | 5 | CID000121907 | |
| Drug | mAHP | 1.44e-06 | 27 | 71 | 4 | CID000220531 | |
| Drug | noradrealine | CACNA1A CACNA1B CYP1A1 CACNA1C CACNA1D CACNA1E CACNA1F RYR1 RYR2 TSPAN1 ITPR3 | 1.57e-06 | 575 | 71 | 11 | CID000000951 |
| Drug | hydride | CACNA1B CYP1A1 CACNA1E SLC9A9 DHCR7 CFTR ATP6V0A4 SCNN1G GRINA RFT1 HVCN1 RYR1 ITPR3 | 1.61e-06 | 835 | 71 | 13 | CID000000783 |
| Drug | NiCl2 | 1.95e-06 | 119 | 71 | 6 | CID000024385 | |
| Drug | Cinnarizine | 2.41e-06 | 9 | 71 | 3 | DB00568 | |
| Drug | Nimodipine | 2.41e-06 | 9 | 71 | 3 | DB00393 | |
| Drug | Sulfachloropyridazine [80-32-0]; Up 200; 14uM; PC3; HT_HG-U133A | 2.72e-06 | 197 | 71 | 7 | 3769_UP | |
| Drug | C070379 | 2.91e-06 | 199 | 71 | 7 | CID003034747 | |
| Drug | cobalt-60 | CACNA1A CACNA1B CACNA1C CACNA1D CACNA1E CACNA1F RYR1 RYR2 ITPR3 | 3.38e-06 | 390 | 71 | 9 | CID000061492 |
| Drug | PCB 95 | 3.43e-06 | 10 | 71 | 3 | CID000038012 | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 1.28e-08 | 3 | 70 | 3 | DOID:0111181 (implicated_via_orthology) | |
| Disease | migraine (implicated_via_orthology) | 5.11e-08 | 4 | 70 | 3 | DOID:6364 (implicated_via_orthology) | |
| Disease | Timothy syndrome (implicated_via_orthology) | 5.11e-08 | 4 | 70 | 3 | DOID:0060173 (implicated_via_orthology) | |
| Disease | hereditary ataxia (implicated_via_orthology) | 4.44e-07 | 7 | 70 | 3 | DOID:0050951 (implicated_via_orthology) | |
| Disease | Long QT Syndrome | 2.08e-06 | 11 | 70 | 3 | C0023976 | |
| Disease | epilepsy (implicated_via_orthology) | 2.54e-06 | 163 | 70 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 1.66e-05 | 3 | 70 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 1.66e-05 | 3 | 70 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | Arrhythmogenic Right Ventricular Dysplasia | 1.66e-05 | 3 | 70 | 2 | C0349788 | |
| Disease | functional colonic disease (biomarker_via_orthology) | 1.66e-05 | 3 | 70 | 2 | DOID:3877 (biomarker_via_orthology) | |
| Disease | Anhedonia | 2.50e-05 | 24 | 70 | 3 | C0178417 | |
| Disease | Idiopathic bronchiectasis | 3.32e-05 | 4 | 70 | 2 | cv:C0339985 | |
| Disease | Bronchiectasis | 3.32e-05 | 4 | 70 | 2 | cv:C0006267 | |
| Disease | Idiopathic bronchiectasis | 3.32e-05 | 4 | 70 | 2 | C0339985 | |
| Disease | longitudinal BMI measurement | 4.42e-05 | 82 | 70 | 4 | EFO_0005937 | |
| Disease | Chronic obstructive pulmonary disease | 8.27e-05 | 6 | 70 | 2 | cv:C0024117 | |
| Disease | Sick Sinus Syndrome | 8.27e-05 | 6 | 70 | 2 | C0037052 | |
| Disease | primary pulmonary hypertension (is_implicated_in) | 8.27e-05 | 6 | 70 | 2 | DOID:14557 (is_implicated_in) | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 8.63e-05 | 36 | 70 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | Early Pregnancy Loss | 1.34e-04 | 109 | 70 | 4 | C3830362 | |
| Disease | Spontaneous abortion | 1.34e-04 | 109 | 70 | 4 | C0000786 | |
| Disease | Miscarriage | 1.34e-04 | 109 | 70 | 4 | C4552766 | |
| Disease | Abortion, Tubal | 1.34e-04 | 109 | 70 | 4 | C0000822 | |
| Disease | Bipolar Disorder | 1.38e-04 | 477 | 70 | 7 | C0005586 | |
| Disease | Brugada syndrome | 1.54e-04 | 8 | 70 | 2 | cv:C1142166 | |
| Disease | irritable bowel syndrome (biomarker_via_orthology) | 1.54e-04 | 8 | 70 | 2 | DOID:9778 (biomarker_via_orthology) | |
| Disease | Anxiety States, Neurotic | 1.58e-04 | 44 | 70 | 3 | C0376280 | |
| Disease | Anxiety neurosis (finding) | 1.58e-04 | 44 | 70 | 3 | C1279420 | |
| Disease | Anxiety Disorders | 1.58e-04 | 44 | 70 | 3 | C0003469 | |
| Disease | Pulmonary Cystic Fibrosis | 1.98e-04 | 9 | 70 | 2 | C0392164 | |
| Disease | Fibrocystic Disease of Pancreas | 1.98e-04 | 9 | 70 | 2 | C1527396 | |
| Disease | lifestyle measurement, systolic blood pressure | 1.98e-04 | 9 | 70 | 2 | EFO_0006335, EFO_0010724 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 2.47e-04 | 10 | 70 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 2.47e-04 | 10 | 70 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | Tachycardia, Ventricular | 3.01e-04 | 11 | 70 | 2 | C0042514 | |
| Disease | Cystic Fibrosis | 3.01e-04 | 11 | 70 | 2 | C0010674 | |
| Disease | aortic measurement | 3.30e-04 | 251 | 70 | 5 | EFO_0020865 | |
| Disease | Hypertrophic Cardiomyopathy | 3.41e-04 | 57 | 70 | 3 | C0007194 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 3.61e-04 | 12 | 70 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Sudden infant death syndrome | 3.61e-04 | 12 | 70 | 2 | C0038644 | |
| Disease | colitis (implicated_via_orthology) | 4.25e-04 | 13 | 70 | 2 | DOID:0060180 (implicated_via_orthology) | |
| Disease | chronic obstructive pulmonary disease (is_implicated_in) | 4.58e-04 | 63 | 70 | 3 | DOID:3083 (is_implicated_in) | |
| Disease | asthma (is_implicated_in) | 5.38e-04 | 157 | 70 | 4 | DOID:2841 (is_implicated_in) | |
| Disease | Mood Disorders | 6.94e-04 | 168 | 70 | 4 | C0525045 | |
| Disease | ischemia (implicated_via_orthology) | 7.37e-04 | 17 | 70 | 2 | DOID:326 (implicated_via_orthology) | |
| Disease | Anorexia | 8.28e-04 | 18 | 70 | 2 | C0003123 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 9.22e-04 | 80 | 70 | 3 | DOID:6432 (biomarker_via_orthology) | |
| Disease | Hypertensive disease | 1.10e-03 | 190 | 70 | 4 | C0020538 | |
| Disease | Dystonia | 1.14e-03 | 86 | 70 | 3 | C0013421 | |
| Disease | Bronchiectasis | 1.24e-03 | 22 | 70 | 2 | C0006267 | |
| Disease | trans fatty acid measurement, trans/trans-18:2 fatty acid measurement | 1.48e-03 | 24 | 70 | 2 | EFO_0006821, EFO_0006826 | |
| Disease | Brugada Syndrome (disorder) | 1.48e-03 | 24 | 70 | 2 | C1142166 | |
| Disease | uveitis (biomarker_via_orthology) | 1.61e-03 | 25 | 70 | 2 | DOID:13141 (biomarker_via_orthology) | |
| Disease | Involutional paraphrenia | 1.61e-03 | 25 | 70 | 2 | C1571983 | |
| Disease | Psychosis, Involutional | 1.61e-03 | 25 | 70 | 2 | C1571984 | |
| Disease | Involutional Depression | 1.61e-03 | 25 | 70 | 2 | C0011574 | |
| Disease | Endogenous Hyperinsulinism | 1.74e-03 | 26 | 70 | 2 | C1257963 | |
| Disease | Exogenous Hyperinsulinism | 1.74e-03 | 26 | 70 | 2 | C1257964 | |
| Disease | Compensatory Hyperinsulinemia | 1.74e-03 | 26 | 70 | 2 | C1257965 | |
| Disease | Bradycardia | 1.74e-03 | 26 | 70 | 2 | C0428977 | |
| Disease | white matter integrity, age at assessment | 1.74e-03 | 26 | 70 | 2 | EFO_0004641, EFO_0008007 | |
| Disease | cystic fibrosis (is_implicated_in) | 1.87e-03 | 27 | 70 | 2 | DOID:1485 (is_implicated_in) | |
| Disease | Hyperinsulinism | 2.02e-03 | 28 | 70 | 2 | C0020459 | |
| Disease | Ciliopathies | 2.30e-03 | 110 | 70 | 3 | C4277690 | |
| Disease | Hyperglycemia, Postprandial | 2.31e-03 | 30 | 70 | 2 | C1855520 | |
| Disease | Hyperglycemia | 2.31e-03 | 30 | 70 | 2 | C0020456 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CVIVFIIILFIVLFA | 81 | Q9BV40 | |
| FVNIFVALIIITFQE | 1501 | O00555 | |
| LVELIITFQLVFTIF | 161 | P55087 | |
| IFDFIQLLLIVIGAI | 991 | P13569 | |
| KNFIIFLVFLNTIIL | 111 | Q96P56 | |
| FIIVFILLLRFFINE | 161 | Q7RTX7 | |
| PFFFVNIFVALIIIT | 1411 | Q15878 | |
| VNFFFLLNIVRVLVT | 311 | P30988 | |
| FQFLFIDLAIILVVV | 966 | Q9H7F0 | |
| FLLFLIIIIVFLVIN | 136 | P36896 | |
| QALVDVSFFILILLL | 1061 | Q8N139 | |
| AVIILINLVFYFQVL | 346 | Q86SQ3 | |
| VLVNVLQAIYVIDFF | 271 | Q9UBM7 | |
| FFVNIFVALIIITFQ | 1406 | Q00975 | |
| IVQLFFFILLGVTEF | 96 | Q96RD1 | |
| QVLFRLITFVLNAFI | 21 | Q96AA3 | |
| EVFLFLAILLQRVEF | 466 | P04798 | |
| VIFVIAVAVILLVFQ | 186 | Q7Z602 | |
| FFIVIIIVLNLIFGV | 2501 | Q14573 | |
| LAVEVLFILDIVLNF | 266 | Q9ULD8 | |
| LDFIIVVVGLFSVLL | 166 | O60840 | |
| SIIFCVIALLVFVFQ | 71 | P54849 | |
| QILKIFVDNLFAIVL | 496 | Q9HBG6 | |
| VVLFIFAILCIFIRN | 291 | Q7Z429 | |
| VVVVVSFILDIVLLF | 176 | Q96D96 | |
| EVFLFNDLLVVTKIF | 996 | Q5JU85 | |
| LIAVVFAVLLFCEFL | 26 | Q53F39 | |
| ILRFPVFLAILINFF | 306 | P47871 | |
| VFLAILINFFIFVRI | 311 | P47871 | |
| LINFFIFVRIVQLLV | 316 | P47871 | |
| RVFLFEQIVIFSELL | 2146 | O60229 | |
| LLINFVFLFNIVRIL | 276 | Q13324 | |
| KILLFVVVAVFLFLV | 416 | P42167 | |
| VLNLFISVILVAFSE | 2386 | Q7Z442 | |
| ILVDFAINAFIILIT | 196 | Q8NGY6 | |
| LILLILSVVFVFFRQ | 696 | Q9UKF2 | |
| SLVFVLLFIFVKRQI | 21 | Q9BWL3 | |
| FLIIFTVEAFLKVIA | 166 | Q13936 | |
| IVNDTIFTNLILFFI | 896 | Q13936 | |
| FDFLIVIGSIIDVIL | 1306 | Q13936 | |
| QIIHFVLFVVFSLVI | 36 | A6NFR6 | |
| FLIFILFIIVQLFIM | 296 | O95727 | |
| VNFAVILDFLVNLLE | 256 | P12111 | |
| VLFVIFILVVLFIVF | 4161 | Q8TDW7 | |
| ILVLLINFIFLFNIV | 306 | P34998 | |
| ILLEDVFQLGQFIFI | 211 | Q674R7 | |
| VVLVLSLQAVAFFVL | 146 | Q6UWJ8 | |
| ILGVVLLAIFVALFF | 1056 | Q86VB7 | |
| VIEIIEVFFIDFFSI | 546 | P51170 | |
| GVIICVFIIFLLIFI | 226 | Q9HBV2 | |
| VFIIFLLIFIIINWA | 231 | Q9HBV2 | |
| FIIILGVANLIVQFF | 546 | Q8NBW4 | |
| FFFFVIVILLAIIQG | 4921 | P21817 | |
| FFFVIVILLAIIQGL | 4851 | Q92736 | |
| VEISIFFIIYIIIVA | 1126 | Q01668 | |
| ELVDFILAFIILVFP | 196 | Q6IFH4 | |
| GLFVVSFFVLNLVLI | 201 | Q8NH60 | |
| VQRVLFVVFLLIYVV | 21 | Q8NH37 | |
| LNICVFILLLVFIVV | 226 | Q96DX8 | |
| AVELLVFNFLLILTI | 21 | Q8IVB4 | |
| EVIVFIKVVQFFRIL | 706 | Q4G0N8 | |
| FLVFLIILFCNLVII | 196 | P25105 | |
| FLLLAAITVLAVVFQ | 606 | O15197 | |
| NLTLVLAIIVFIFAV | 841 | Q14524 | |
| INLVFIVLFTGEFVL | 1561 | Q9NY46 | |
| IFFVVFLIVYLVNVV | 26 | Q8NGP9 | |
| ELVDFILAFIILVFP | 196 | Q8NGW1 | |
| LVVVIVASFFILKNF | 146 | Q9UNL2 | |
| LFLVFVVIVFVFIEK | 26 | Q7LGC8 | |
| IFLQLFIFYVNVIVI | 56 | Q9NYW7 | |
| LFIIQDIAVLFNIII | 41 | Q9NPI0 | |
| IVILLLVDVVYIFFD | 166 | P56180 | |
| FLTLVFLVELVAAIV | 96 | O43657 | |
| NLLQAVFFVLFVLSV | 81 | A0A1B0GTY4 | |
| IFAVFAVLTVAILLI | 781 | Q9HBG4 | |
| LFFDVEALIIQLLTE | 691 | Q9Y4E6 | |
| IFGILFAILLVLVFI | 201 | P25942 | |
| FILLLIFIAEVAAAV | 91 | O60635 |